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Adverse childhood experiences (ACEs) include verbal, 
physical, or sexual abuse, as well as family dysfunction (e.g., an 
incarcerated, mentally ill, or substance-abusing family member; 
domestic violence; or absence of a parent because of divorce or 
separation). ACEs have been linked to a range of adverse health 
outcomes in adulthood, including substance abuse, depression, 
cardiovascular disease, diabetes, cancer, and premature mortality 
(1–3). Furthermore, data collected from a large sample of health 
maintenance organization members indicated that a history 
of ACEs is common among adults and ACEs are themselves 
interrelated (4). To examine whether a history of ACEs was 
common in a randomly selected population, CDC analyzed 
information from 26,229 adults in five states using the 2009 
ACE module of the Behavioral Risk Factor Surveillance System 
(BRFSS). This report describes the results of that analysis, which 
indicated that, overall, 59.4% of respondents reported having 
at least one ACE, and 8.7% reported five or more ACEs. The 
high prevalence of ACEs underscores the need for 1) additional 
efforts at the state and local level to reduce and prevent child 
maltreatment and associated family dysfunction and 2) further 
development and dissemination of trauma-focused services to 
treat stress-related health outcomes associated with ACEs.
BRFSS is a surveillance system operated by state health 
departments in collaboration with CDC. Each month, trained 
interviewers using a standardized questionnaire collect data 
from a probability sample of the noninstitutionalized U.S. adult 
population residing in households with landline telephones. The 
2009 ACE module consisted of 11 questions that yielded eight 
categories of ACEs (i.e., verbal abuse, physical abuse, sexual 
abuse, household mental illness, household substance abuse, 
domestic violence, parental separation/divorce, and incarcer-
ated family members). These questions were adapted from 
large, validated survey instruments measuring the frequency 
of these ACEs.* The ACE module was implemented in five 
states (Arkansas, Louisiana, New Mexico, Tennessee, and 
Adverse Childhood Experiences Reported by Adults — Five States, 2009
* The 11 ACE questions were modified from the Kaiser-CDC ACE study questions 
(1) to conform to fewer BRFSS question response categories and were tested for 
understanding using focus groups. Respondents were told that the 11 questions 
referred to the time before they were aged 18 years. Less than 0.5% responded 
“don’t know or not sure” to any one of the questions, which was defined as a 
negative response for that ACE category. Verbal abuse was defined as a “more than 
once” response to the question “How often did a parent or adult in your home 
ever swear at you, insult you, or put you down?” in contrast to “never,” “once,” 
or “don’t know/not sure.” Physical abuse was defined for a response of either 
“once” or “more than once” to the question “How often did your parents or an 
adult in your home ever hit, beat, kick, or physically hurt you in any way? Do 
not include spanking.” Sexual abuse was defined for a response of either “once” 
or “more than once” to any one of the three following questions: “How often 
did anyone at least 5 years older than you or an adult, ever touch you sexually?”, 
“How often did anyone at least 5 years older than you or an adult try to make 
you touch them sexually?”, or “How often did anyone at least 5 years older than 
you or an adult, force you to have sex?” Two separate household dysfunction 
variables were defined by affirmative responses to questions about living with 
anyone who “was depressed, mentally ill, or suicidal” or “served time or was 
sentenced to serve time in a prison, jail, or other correctional facility.” Living 
with a household substance abuser was defined by an affirmative response to at 
least one of two questions about living with anyone who “was a problem drinker 
or alcoholic” or “used illegal street drugs or abused prescription medications.” 
Having “parents who were separated or divorced” was defined by an affirmative 
response to a question asking about that in contrast to those answering “no,” 
“don’t know/not sure,” or “parents not married.” Witnessing domestic violence 
was defined by either a response of “once” or “more than once” to the question 
“How often did your parents or adults in your home ever slap, hit, kick, punch, 
or beat each other up.”
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Washington). Response rates for these states, calcu-
lated using the Council of American Survey Research 
Organizations (CASRO) guidelines, ranged from 
48.2% to 59.8%.
Among the 29,212 adult survey participants, 1,757 
(6.0%) who terminated the telephone call before the ACE 
module was administered and another 1,226 (4.2%) who 
refused to answer at least one of the 11 ACE questions 
were excluded. Thus, the sample included 26,229 (89.8%) 
of the interviewed BRFSS participants. 
The prevalence of each ACE ranged from a high 
of 29.1% for household substance abuse to a low 
of having an incarcerated family member (7.2%) 
(Table 1). Approximately one quarter (25.9%) of respon-
dents reported verbal abuse, 14.8% reported physical 
abuse, and 12.2% reported sexual abuse. For ACEs mea-
suring family dysfunction, 26.6% reported separated or 
divorced parents; 19.4% reported that they had lived with 
someone who was depressed, mentally ill, or suicidal; and 
16.3% reported witnessing domestic violence.
Men and women reported similar prevalences for 
each ACE, with the exception of sexual abuse (17.2% 
for women and 6.7% for men [p<0.05]), living with 
a mentally ill household member (22.0% for women 
and 16.7% for men [p<0.05]), and living with a 
substance-abusing family member (30.6% for women 
and 27.5% for men [p<0.05]). Younger respondents 
more often reported living with an incarcerated and/
or mentally ill household member (p<0.05).
For each ACE, a sharp decrease was observed in 
prevalence reported by adults aged ≥55 years (p<0.05). 
For example, the prevalence of reported physical 
abuse was 16.9% among adults aged 18–24 years 
compared with 9.6% among those aged ≥55 years 
(p<0.05). Non-Hispanic black respondents reported 
the lowest prevalence of each ACE category among all 
racial/ethnic groups (p<0.05), with the exception of 
having had an incarcerated family member, parental 
separation or divorce, and witnessing domestic vio-
lence. Hispanics reported a higher prevalence than 
non-Hispanic whites of physical abuse (p<0.05), 
witnessing domestic violence (p<0.05), and having 
an incarcerated family member (p<0.05). Those 
respondents with less than a high school education 
compared with those with more than a high school 
education had a greater prevalence of physical abuse, 
an incarcerated family member, substance abuse, and 
separation/divorce (p<0.05 for all). Among the five 
states, little variation was observed (Table 1). 
Approximately 41% of respondents reported 
having no ACEs (Table 2), 22% reported one ACE, 
and 8.7% reported five or more ACEs (Table 2). 
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Men (6.9%) were less likely to report five or more 
ACEs compared with women (10.3%). Respondents 
aged ≥55 years reported the fewest ACEs, but the 
younger age groups did not differ from one another. 
Non-Hispanic blacks were less likely to report five 
or more ACEs (4.9%) compared with non-Hispanic 
whites (8.9%), Hispanics (9.1%), and other non-
Hispanics (11.7%). However, non-Hispanic black 
respondents were not significantly more likely to 
report zero ACEs compared with other racial/ethnic 
groups. Respondents with the lowest educational 
attainment were significantly more likely to report 
five or more ACEs compared with those with higher 
education levels (14.9% versus 8.7% among high 
school graduates and 7.7% in those with more than 
a high school education [p<0.05]). Overall, little 
state-by-state variation was observed in the number 
of ACEs reported by each respondent. 
Reported by
L Bynum, Arkansas Dept of Health. T Griffin, Louisiana 
Dept of Health. DL Ridings, Tennessee Dept of Health. 
KS Wynkoop, Washington Dept of Health. RF Anda, 
MD, Carter Consulting, Inc., Atlanta, Georgia. 
VJ Edwards, PhD, TW Strine, PhD, Y Liu, PhD, 
LR McKnight-Eily, PhD, JB Croft, PhD, Div of Adult 
and Community Health, National Center for Chronic 
Disease Prevention and Health Promotion, CDC.
Editorial Note
This is the first published report to document 
the prevalence of ACEs in a population-based rep-
resentative sample from multiple states stratified 
by demographic characteristics, including sex, age, 
education, and race/ethnicity. Approximately 59% 
of respondents reported one or more ACEs. These 
BRFSS estimates are similar to the findings in the 
Kaiser-CDC ACE study (2) and similar research, 
including a study in Texas (5,6).† Sexual abuse, fam-
ily mental illness, and family substance abuse were 
reported more commonly by women than men. 
Although differences were observed in the prevalence 
of individual ACEs and number of ACEs, this study 
found that ACEs were common among all racial/
† Additional information available at http://www.cdc.gov/pcd/
issues/2010/may/09_0158.htm.
TABLE 1. Percentage of adults aged ≥18 years reporting adverse childhood experiences (ACEs), by ACE category and selected characteristics — 





















% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Total* 26,229 25.9 (25.0–26.9) 14.8 (14.0–15.6) 12.2 (11.5–12.9) 19.4 (18.5–20.4) 7.2 (6.5–7.9) 29.1 (28.1–30.2) 26.6 (25.5–27.7) 16.3 (15.5–17.2)
Sex
Men 9,474 24.8 (23.3–26.4) 14.1 (13.0–15.5) 6.7 (5.9–7.7) 16.7 (15.3–18.3) 7.7 (6.5–9.1) 27.5 (25.8–29.3) 26.5 (24.7–28.3) 15.7 (14.4–17.1)
Women 16,755 26.9 (25.8–28.1) 15.4 (14.5–16.3) 17.2 (16.3–18.2) 22.0 (20.9–23.1) 6.7 (6.0–7.5) 30.6 (29.4–31.8) 26.7 (25.5–27.9) 16.9 (15.9–17.9)
Age group (yrs)
 18–24 764 26.9 (22.9–31.2) 16.9 (13.6–20.7) 8.0 (5.9–10.8) 26.6 (22.6–31.1) 15.4 (12.4–19.0) 29.6 (25.6–34.1) 38.0 (33.3–43.0) 18.6 (15.1–22.5)
 25–34 2,103 32.7 (29.6–33.9) 17.9 (15.4–20.7) 13.3 (11.2–15.7) 25.7 (23.0–28.5) 13.9 (11.4–16.9) 35.6 (32.4–38.9) 40.0 (36.4–43.1) 20.8 (18.1–23.8)
 35–44 3,388 28.2 (25.8–30.6) 15.8 (14.0–17.8) 14.5 (12.8–16.3) 21.6 (19.2–24.2) 7.0 (5.4–9.0) 32.0 (29.2–34.8) 33.0 (30.2–35.9) 17.4 (15.5–19.5)
 45–54 11,504 26.9 (25.7–28.1) 14.6 (13.7–15.6) 12.5 (11.7–13.4) 18.3 (17.3–19.4) 4.5 (3.9–5.2) 29.3 (30.0–30.6) 19.8 (18.7–21.0) 16.2 (15.2–17.3)
 ≥55 8,336 13.5 (12.5–14.6) 9.6 (8.7–10.7) 9.3 (8.4–10.3) 9.0 (8.2–9.9) 2.2 (1.8–2.8) 18.2 (17.0–19.4) 12.9 (11.9–13.9) 9.4 (8.5–10.4)
Race/Ethnicity
White, non-Hispanic 19,770 26.9 (25.8–28.0) 14.6 (13.7–15.6) 11.9 (11.2–12.7) 20.6 (19.5–21.7) 6.2 (5.4–7.0) 29.1 (27.9 –30.3) 25.2 (24.0–26.4) 15.1 (14.2–16.1)
Black, non-Hispanic 2,662 16.0 (13.7–18.7) 8.4 (6.8–10.3) 11.0 (8.6–13.9) 11.4 (9.1–14.2) 12.9 (10.1–16.4) 26.3 (22.9–29.9) 37.9 (34.3–41.7) 17.7 (14.9–20.9)
Hispanic 2,217 26.0 (23.2–29.0) 19.8 (17.2–22.7) 14.8 (12.3–17.6) 16.8 (14.1–19.8) 9.5 (7.6–11.7) 33.4 (29.9–37.0) 25.7 (22.7–29.0) 21.7 (18.9–24.8)
Other, non-Hispanic† 1,381 31.4 (26.9–36.3) 21.9 (17.8–26.6) 14.7 (12.0–17.8) 22.4 (18.8–26.4) 6.6 (4.9–9.0) 29.4 (25.3–33.8) 25.6 (21.6–30.0) 23.0 (19.2–27.4)
Education
<High school 2,646 26.5 (22.8–30.6) 20.4 (17.0–24.2) 15.7 (13.0–18.8) 19.2 (15.4–23.8) 16.6 (12.5–21.7) 37.7 (33.4–42.3) 37.0 (32.5–41.6) 22.6 (19.1–26.6)
High school 7,379 21.7 (20.0–23.4) 13.9 (12.6–15.4) 10.8 (9.5–12.2) 16.7 (15.1–18.4) 9.2 (7.8–10.8) 28.9 (27.0–31.0) 29.0 (26.9–31.1) 17.5 (15.8–19.2)
>High school 16,175 27.7 (26.6–28.9) 14.3 (13.4–15.3) 12.3 (11.5–13.1) 20.7 (19.6–21.8) 4.9 (4.3–5.5) 27.9 (26.7–29.2) 24.0 (22.8–25.3) 14.9 (14.0–15.9)
State
Arkansas 3,558 24.3 (22.1–26.6) 14.1 (12.3–16.1) 10.9 (9.5–12.5) 17.0 (15.1–19.2) 5.5 (4.2–7.0) 25.5 (23.3–27.8) 23.3 (21.1–25.6) 15.1 (13.3–17.1)
Louisiana 8,147 21.1 (19.8–22.5) 10.5 (9.6–11.6) 9.9 (9.1–10.8) 16.6 (15.4–17.9) 7.2 (6.3–8.2) 26.6 (25.2–28.1) 27.1 (25.6–28.7) 14.5 (13.4–15.7)
New Mexico 5,271 28.1 (26.3–30.0) 19.5 (17.8–21.3) 12.9 (11.6–14.4) 19.4 (17.8–21.1) 7.1 (5.9–8.5) 29.9 (28.0–31.8) 24.4 (22.6–26.3) 18.9 (17.2–20.7)
Tennessee 2,327 19.2 (16.8–21.9) 12.9 (10.9–15.2) 12.7 (10.8–14.7) 17.1 (14.7–19.9) 8.6 (6.6–11.2) 28.3 (25.4–31.5) 29.1 (26.0–32.4) 17.1 (14.8–19.6)
Washington 6,926 34.9 (33.4–36.5) 18.1 (16.9–19.4) 13.5 (12.5–14.6) 24.3 (22.9–25.7) 6.6 (5.8–7.6) 32.7 (31.2–34.2) 26.0 (24.6–27.5) 16.6 (15.4–17.8)
Abbreviation: CI = confidence interval.
* Percentages might not total to 100% because of rounding.
† Includes Asian, non-Hispanic; Native Hawaiian/Pacific Islander, non-Hispanic; American Indian/Alaska Native, non-Hispanic; other race, non-Hispanic; and multiracial, non-Hispanic.
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ethnic groups. Participants aged ≥55 years reported 
significantly lower prevalences of all ACE categories 
than each of the younger age groups.
These findings reinforce the commonality of ACEs 
across racial/ethnic groups and states. Differences in 
reporting family mental illness and substance abuse by 
women might represent greater comfort with disclos-
ing family problems. However, sexual abuse has been 
consistently reported by more women than men in 
many surveys and agencies’ statistics, and this study 
confirms that finding. The markedly lower prevalences 
for all the ACE categories among those aged ≥55 years 
were similar to findings from the Kaiser-CDC ACE 
study (1), which suggested that a higher number of 
ACEs were associated with premature mortality (up 
to 20 years of life lost). Additionally, growing up with 
a family member in prison was inversely related to 
age; this might reflect the rising level of incarceration 
among the U.S. population.§ 
The findings in this report are subject to at least 
four limitations. First, the prevalences of ACEs might 
be underestimated because BRFSS excludes persons 
in institutions and hospitals, who might have expe-
rienced ACEs disproportionately. Second, BRFSS 
excludes persons who rely on cellular telephones as 
their only telephone service, thus underestimating 
the prevalence of ACES among persons aged 18–35 
years or those more likely to use only a cellular phone. 
Third, this study covered only five states, and the 
results are not generalizeable to the entire U.S. adult 
population. Finally, BRFSS response rates were low, 
which increases the risk for response bias.
State-based surveillance of ACEs can provide guid-
ance for the allocation of maltreatment prevention 
strategies and trauma-related intervention services.¶ In 
addition, more research is needed to disentangle the 
specific role each ACE plays in the development of 
health problems later in life. As it currently exists, the 
ACE total captures the cumulative risk associated with 
TABLE 2. Percentage of adults aged ≥18 years reporting adverse childhood experiences (ACEs), by number of ACEs reported and selected 




0 ACEs 1 ACEs 2 ACEs 3 ACEs 4 ACEs ≥5 ACEs
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Total* 26,229 40.6 (39.5–41.7) 22.4 (21.5–23.3) 13.1 (12.3–13.9) 8.8 (8.2–9.4) 6.5 (5.9 –7.2) 8.7 (8.0–9.4)
Sex
Men 9,474 42.0 (40.2–43.9) 23.3 (21.8–24.8) 13.4 (12.2–14.8) 7.8 (6.9–8.7) 6.6 (5.5–7.9) 6.9 (6.0–8.0)
Women 16,755 39.2 (38.0–40.4) 21.6 (20.6–22.6) 12.8 (11.9–13.6) 9.7 (9.0–10.6) 6.4 (5.8–7.1) 10.3 (9.5–11.2)
Age group (yrs)
 18–24 764 35.5 ( 30.7– 40.6) 22.6 ( 18.6–27.2) 13.2 (10.3– 16.8) 7.6 ( 5.6– 10.3) 8.5 ( 6.2–11.7) 12.5 ( 9.8– 15.9)
 25–34 2,103 31.1 (28.1–34.4) 21.9 (19.4–24.8) 14.9 (12.6–17.6) 8.9 (7.3–10.7) 8.9 (7.1–11.1) 14.2 (11.9–16.9)
 35–44 3,388 35.7 (33.0–38.6) 22.2 (20.0–24.5) 13.9 (12.0–16.1) 10.9 (9.4–12.7) 7.4 (5.7–9.7) 9.8 (8.5–11.4)
 45–54 11,504 41.8 (40.4–43.3) 22.4 (21.2–23.5) 13.3 (12.4–14.2) 9.3 (8.5–10.1) 5.9 (5.3–6.6) 7.4 (6.7–8.1)
 >55 8,336 56.7 (55.1–58.2) 22.9 (21.6–24.2) 9.6 (8.8–10.5) 5.4 (4.8–6.2) 3.0 (2.5–3.5) 2.5 (2.0–3.0)
Race/Ethnicity
White, non-Hispanic 19,770 41.7 (40.4–43.0) 22.0 (21.0–23.0) 12.7 (11.9–13.6) 8.7 (8.0–9.4) 6.0 (5.4–6.8) 8.9 (8.1–9.7)
Black, non-Hispanic 2,662 37.3 (33.9–40.9) 27.0 (23.9–30.4) 13.8 (11.4–16.7) 8.9 (7.1–11.1) 8.0 (5.6–11.3) 4.9 (3.7–6.6)
Hispanic 2,217 35.7 (32.2–39.4) 23.5 (20.6–26.7) 12.9 (10.6–15.5) 10.3 (8.0–13.1) 8.6 (6.7–11.0) 9.1 (7.5–11.0)
Other, non-Hispanic† 1,381 37.8 (33.4–42.3) 18.2 (15.3–21.6) 16.4 (12.3–21.5) 8.4 (5.9–11.7) 7.6 (5.4–10.5) 11.7 (9.3–14.6)
Education
<High school 2,646 34.5 (31.1–38.0) 19.8 (17.3–22.6) 12.6 (10.3–15.3) 10.5 (8.0–13.8) 7.7 (4.7–12.44) 14.9 (11.7–18.8)
High school 7,379 40.9 (38.7–43.1) 23.5 (21.7–25.4) 13.2 (11.7–14.9) 7.9 (6.9–8.9) 5.8 (4.8–7.0) 8.7 (7.6–10.1)
>High school 16,175 41.3 (40.0–42.7) 22.3 (21.2–23.4) 13.1 (12.2–14.1) 9.0 (8.3–9.7) 6.6 (5.9–7.4) 7.7 (7.1–8.5)
State
Arkansas 3,558 46.9 (44.5–49.4) 21.0 (19.0–23.0) 11.2 (9.8–12.9) 7.1 (5.9–8.4) 5.9 (4.7–7.3) 8.0 (6.5–9.7)
Louisiana 8,147 42.6 (41.0–44.1) 24.7 (23.3–26.2) 12.9 (11.8–14.0) 7.7 (6.9–8.7) 5.5 (4.8–6.3) 6.6 (5.8–7.5)
New Mexico 5,271 39.0 (36.9–41.1) 21.8 (20.2–23.6) 12.6 (11.3–13.9) 10.1 (8.7–11.5) 7.1 (6.0–8.3) 9.5 (8.4–10.8)
Tennessee 2,327 43.5 (40.4–46.7) 20.8 (18.4–23.5) 12.6 (10.5–15.0) 8.3 (6.8–10.1) 6.2 (4.4–8.6) 8.7 (7.0–10.7)
Washington 6,926 34.6 (33.1–36.1) 23.0 (21.7–24.3) 14.6 (13.5–15.8) 10.3 (9.4–11.2) 7.5 (6.7–8.4) 10.1 (9.1–11.1)
Abbreviation: CI = confidence interval.
* Percentages might not total to 100% because of rounding.
† Includes Asian, non-Hispanic; Native Hawaiian/Pacific Islander, non-Hispanic; American Indian/Alaska Native, non-Hispanic; other race, non-Hispanic; and multiracial, 
non-Hispanic. 
§ Additional information available at http://www.justicepolicy.org/
images/upload/00-05_rep_punishingdecade_ac.pdf. ¶ Additional information available at http://www.samhsa.gov/nctic/
default.asp.
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child maltreatment and family dysfunction, but could be 
further refined to address issues of unequal severity. 
CDC is developing, evaluating, and promoting 
dissemination of programs for the primary prevention 
of child maltreatment.** Evidence-based programs 
exist that have demonstrated reductions in child mal-
treatment, such as home visits by nurses to mothers at 
high risk (7) and parenting programs that teach new 
skills and behaviors to parents (8). However, most 
child maltreatment goes undetected, as evidenced by 
the discrepancy between the incidence of confirmed 
cases of abuse reported by child protective services 
and retrospectively reported prevalences such as 
those described in this report. Therefore, secondary 
and tertiary efforts are important complementary 
approaches to primary prevention efforts to improve 
the health and well-being of affected adults and 
families. Psychological treatments that can mitigate 
the progression of ACE-related health problems, such 
as trauma-focused cognitive-behavioral therapy, are 
effective (9) and should be widely disseminated. Other 
promising public health programs, such as trauma 
survivors’ networks (10), should be more systemati-
cally evaluated to add to the repertoire of available 
evidence-based interventions that can prevent and 
alleviate the stress-related health risk behaviors, condi-
tions, and disability associated with ACEs. 
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What is already known on this topic?
Adverse childhood experiences (ACEs) are common 
and are associated with multiple mental and physical 
health problems.
What does this report add?
ACE prevalences range from a low of 6.7% of respon-
dents reporting having had a family member in prison 
to 29.1% reporting living with a substance-abusing 
household member. Reporting multiple ACEs was com-
mon; 8.7% of respondents reported five or more ACEs. 
What are the implications for public health practice?
Evidence-based child abuse prevention programs, 
such as home visitations and parenting programs, 
might improve health by reducing ACEs.
 ** Additional information available at http://www.cdc.gov/
violenceprevention/childmaltreatment/index.html.
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In recent years, Iraqi refugees have been resettling in 
the United States in large numbers, with approximately 
28,000 arrivals during October 2007–September 
2009 (federal fiscal years [FYs] 2008 and 2009). All 
refugees undergo a required medical examination 
before departure to the United States to prevent 
importation of communicable diseases, including 
active tuberculosis (TB), as prescribed by CDC 
Technical Instructions (1). CDC also recommends 
that refugees receive a more comprehensive medical 
assessment after arrival, which typically occurs within 
the first 90 days of arrival. To describe the health 
profile of resettled Iraqi refugees, post-arrival medical 
assessment data were reviewed for 5,100 Iraqi refugees 
who underwent full or partial assessments at the San 
Diego County refugee health clinic during FYs 2008 
and 2009. Among 4,923 screened refugees aged >1 
year, 692 (14.1%) had latent tuberculosis infection 
(LTBI); among 3,047 screened adult refugees aged 
>18 years, 751 (24.6%) were classified as obese; and 
among 2,704 screened adult refugees, 410 (15.2%) 
were hypertensive. Although infectious illness has 
been the traditional focus of refugee medical screen-
ing (2), a high prevalence of chronic, noninfectious 
conditions that could lead to serious morbidity was 
observed among Iraqi refugees. Public health agen-
cies should be aware of the potentially diverse health 
profiles of resettling refugee groups. Medical assess-
ment of arriving refugee populations, with timely 
collection and review of health data, enables early 
detection, treatment, and follow-up of conditions, 
and can help public health agencies develop and set 
priorities for population-specific health interventions 
and guidelines.
During FYs 2008 and 2009, California received 
24% (6,626) of all U.S.-bound Iraqi refugees, the 
largest proportion of any state (Figure). The California 
Refugee Health Program provides comprehensive, 
standardized medical assessments for all refugees 
within 90 days of arrival. Based on those assess-
ment results, refugees are referred to primary-care 
providers and, if needed, for specialized care. This 
initial assessment, based partially on CDC guidelines 
for arriving refugees (1), includes a history, physi-
cal exam, mental health screening, and laboratory 
screening for infectious conditions such as intestinal 
parasites, TB, syphilis, human immunodeficiency 
virus (HIV), and hepatitis B. Depending on age, 
medical history, and other risk factors, the refugees 
also are assessed for noninfectious conditions such 
as diabetes, hypertension, hyperlipidemia, anemia, 
and lead poisoning. This report describes prevalences 
for selected infectious and noninfectious conditions 
among Iraqi refugees in California, based on data 
from those assessments. 
San Diego County received 5,397 (81%) of the 
6,626 Iraqi refugees who resettled in California dur-
ing FYs 2008 and 2009 (Table 1). Of these, 5,100 
(94.5%) completed at least part of a medical assess-
ment (Table 2), with a median time between arrival 
and assessment of 76 days (range: 1–159 days). 
Denominators varied for different components of 
the medical assessment because of screening criteria 
(e.g., age) and missing data. Although mental health 
screening was performed, the data captured were 
limited and are not presented here. 
LTBI was identified in 692 (14.1%) of 4,923 of 
Iraqi refugees aged >1 year (Table 2). Within the 
subset of this group aged ≥65 years, the prevalence 
of LTBI was 52.3%. The only pathogenic intestinal 
parasites identified by stool examination were Giardia 
intestinalis in 40 (3.1%)and Entamoeba histolytica in 
55 (1.2%) of 4,520 screened refugees; no helminths 
were identified. All other identified species were 
of little or indeterminate clinical significance (e.g., 
Endolimax nana and Blastocystis hominis, respectively) 
(3). Only 21 (0.7%) of 2,957 refugees of any age were 
hepatitis B surface antigen-positive, an indication of 
chronic hepatitis B virus infection. Most resettled 
Iraqi refugees were screened for syphilis and HIV 
during the required overseas examination. Of 28,366 
U.S.-bound Iraqi refugees screened overseas during 
FYs 2008 and 2009, 27 (0.1%) had syphilis, and only 
three (<0.1%) were HIV-infected (CDC, unpub-
lished data, 2010). Among 323 Iraqi refugee arrivals 
in San Diego County who had not been screened 
overseas for syphilis, eight (2.5%) were found to have 
the disease. Among 274 arrivals who had not been 
screened overseas for HIV, only one was found to be 
infected (Table 2). Among refugees aged >18 years, 
Health of Resettled Iraqi Refugees — San Diego County, California, 
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the most frequently diagnosed noninfectious condi-
tions were obesity in 751 (24.6%) of 3,047 persons 
and hypertension in 410 (15.2%) of 2,704 persons.* 
Among those aged ≥65 years, 83 (64.3%) of 129 were 
hypertensive (Table 2). Of refugees aged ≥40 years 
who were screened for hyperlipidemia, 114 (39.9%) 
of 286 had dyslipidemia.† Of children aged <5 years 
with available anthropometric data, 23 (7.1%) of 322 
were acutely malnourished and 348 (29.6%) of 1,175 
women of childbearing age were anemic.§
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Editorial Note
During the past 3 decades, the United States 
has received approximately 3 million refugees from 
diverse countries and regions of the world (4). During 
FYs 2008 and 2009, Iraqi refugees were the largest 
group to resettle in the United States, accounting 
for approximately 21% of all U.S.-resettled refugees.
The traditional focus of refugee medical screening has 
been on communicable diseases (2), and the overseas 
refugee medical examination emphasizes transmissible 
illness such as active TB. However, Iraqi refugees 
were displaced from a middle-income country, where 
the health profile combines some infectious diseases 
prevalent in low-income countries (e.g., TB) with 
chronic conditions seen in the United States (e.g., 
obesity) (5). The prevalence of obesity among Iraqi 
adults (24.6%), for example, nearly equaled the preva-
lence of adult obesity (24.8%) among adult California 
residents (6). Medical screening after arrival provides 
an opportunity to identify important causes of mor-
bidity among resettled refugees that might not have 
been discovered previously, and enables early referral 
for treatment and follow-up care.
This report highlights key clinical findings among 
Iraqi refugees in San Diego and provides screening 
considerations. Chronic, noninfectious conditions 
were prevalent in this population. This finding is sup-
ported by outside data; for example, in a 2009 survey 
of Iraqi refugees in Jordan and Syria, 41%–51% of 
refugees aged ≥18 years reported a diagnosis of chronic 
illness such as hypertension, diabetes, or cardiovas-
cular disease (S. Doocy, Johns Hopkins Bloomberg 
School of Public Health, personal communication, 
2010). The epidemiology of some infectious diseases 
in Iraqi refugees also might differ from other refugee 
groups. For example, although the prevalence of LTBI 
in Iraqi refugees aged ≥65 years was comparable to 
rates in other refugee populations (7), recent data 
from the overseas medical examination indicate that 
prevalences of abnormal chest radiograph (0.7%) 
and culture-confirmed TB (0%) among 28,366 Iraqi 
refugees resettling to the United States during FYs 
2008 and 2009 were much lower than those in other 
recently resettled refugee populations (8). Prevalence 
of chronic hepatitis B virus infection also was lower 
(0.7%) than country estimates (9) for Iraq (2%–7%) 
and substantially lower than prevalences seen in some 
sub-Saharan African and Southeast Asian refugee 






FIGURE. Number of Iraqi refugee arrivals — United States, October 2007–September 
2009
* Obesity was defined as body mass index ≥30 kg/m2; hypertension 
was defined as a systolic blood pressure ≥140 mmHg or diastolic 
blood pressure ≥90 mmHg on two separate measurements.
† Dyslipidemia was defined as elevated low density lipoprotein cholesterol, 
low high-density lipoprotein cholesterol, or elevated triglycerides.
§ Anemic was defined as capillary hemoglobin <12.0 g/dL.
MMWR  Morbidity and Mortality Weekly Report
1616 MMWR  /  December 17, 2010  /  Vol. 59  /  No. 49
Few screened Iraqi refugees had evidence of 
pathogenic intestinal parasites on stool examination 
(G. intestinalis in 3.1% and E. histolytica in 1.2%). 
Although Iraqi refugees resettling to the United States 
from Jordan and Iraq routinely receive presumptive 
antihelminthic treatment with albendazole (1), none 
of the Iraqi refugees assessed in San Diego County 
during FYs 2008 and 2009 (including those from 
Syria, Lebanon, Turkey, and other countries without 
presumptive therapy) had evidence of intestinal hel-
minths on stool microscopy. In contrast, other reset-
tling refugee populations have had rates of pathogenic 
intestinal helminths (e.g., Ascaris spp., Trichuris spp., 
Ancylostoma spp., and Necator americanus) (3) as 
high as 24% (2). However, a recent serologic study 
of 200 Iraqi refugees found that up to 10% were 
infected with strongyloides and 3.5% with Schistosoma 
haematobium (CDC, unpublished data, 2009). Stool 
examination is not a sensitive tool for detection of 
these parasites, which can cause infection leading to 
serious health consequences, including death (3). 
The health profile described in this report can 
help local, state, federal, and international public and 
refugee health agencies identify public health needs 
of Iraqi refugees resettling in the United States, and 
provide clinicians with information about relevant 
medical needs. Considerations for state public health 
agencies and clinicians include the importance of 
evaluation for obesity, hypertension, and dyslipi-
demia during state medical assessments, with careful 
screening for diabetes and heart disease among those 
with risk factors, followed by appropriate referral. 
Culturally appropriate programs should be imple-
mented to promote obesity prevention and control 
among Iraqi refugees.
Testing for LTBI should be encouraged and treat-
ment offered to persons with positive test results. 
Immunization programs in Iraq include bacille 
Calmette-Guerin vaccination, but CDC guidelines 
state that prior immunization should not be con-
sidered in the interpretation of a positive tuberculin 
skin test or interferon gamma release assay for TB 
infection (1). In addition, clinicians should consider 
presumptive treatment or serologic screening for 
strongyloidiasis and schistosomiasis (3), recognizing 
that the single albendazole dose provided during 
presumptive treatment in Iraq and Jordan would not 
eradicate either parasite.
Although rates of chronic malnutrition appear 
low among Iraqi refugee children aged <5 years, some 
young children might be acutely malnourished, per-
haps because of sudden changes in food availability. 
In addition to routine assessment of nutritional status 
with anthropometric measurements and screening for 
anemia, clinicians should evaluate children aged <5 
years for clinical signs of acute malnutrition, such as 
wasting or bilateral edema.
The findings in this report are subject to at least 
three limitations. First, the medical assessment was 
limited to the screening described in this report, the 
results of which might lead to referral for further 
workup. Therefore, diagnosis of other conditions 
anecdotally reported in this group of refugees by over-
seas health-care providers, such as cancers, ischemic 
heart disease, specific mental health diagnoses, and 
familial Mediterranean fever, is beyond the scope of 
the initial assessment. Past medical and family histo-
ries, and screening results for some sexually transmit-
ted diseases (i.e., gonorrhea, chlamydia), also were 
not captured in these data. Second, Iraqi asylees were 
included in this group of refugees, and their profiles 
TABLE 1. Characteristics of arriving Iraqi refugees — San 







 <5 509 (9.4)
 5–18 1,451 (26.9)
 19–25 822 (15.2)
 26–45 1,664 (30.8)
 46–65 777 (14.4)
 ≥65 174 (3.2)







Highest level of education (yrs)¶
None 146 (4.8)
Elementary (1–6) 485 (15.9)
Junior high school (7–8) 274 (9.0)
High school (9–12) 1,130 (37.0)
Some college (13–16) 804 (26.3)
College graduate (>16) 213 (7.0)
* N = 5,397, including 367 refugees who were asylees (sought asylum 
after arrival in the United States rather than before).
† Percentages might not total 100% because of rounding.
§ Immediately before resettling to the United States.
¶ For 3,052 Iraqi refugees aged ≥19 years.
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might differ slightly because they sought asylum after 
arrival in the United States and therefore did not 
receive predeparture medical examinations. Finally, 
many refugees were assessed >90 days after arrival; 
therefore, the original severity of certain conditions 
might not be reflected (e.g., degree of lead poisoning 
or presence of intestinal parasitic infections). Delays 
in medical assessment occurred because the health 
department was not prepared for the marked increase 
in Iraqi refugee arrivals during FYs 2008 and 2009 
(U.S. arrivals increased from approximately 200 in FY 
2007 to approximately 10,000 in FY 2008).
TABLE 2. Selected conditions diagnosed among Iraqi refugees undergoing part or all of the standard refugee medical 
assessment (N = 5,100) — San Diego County, California, October 2007–September 2009






Anemia Children aged <2 yrs: capillary Hgb 
<11.0 g/dL 
>9 mos 5,100 457 (9.0)
<5 yrs 540 89 (16.5)





Males aged ≥2 yrs: capillary Hgb 
<13.0 g/dL
Dyslipidemia Elevated fasting LDL-C or TG or low HDL-C ≥40 yrs 286 114 (39.9)
Glucosuria Urine dipstick glucose results ≥50 mg/dL ≥4 yrs 4,755 69 (1.5)
>18 yrs 3,245 61 (1.9)
Hypertension Systolic blood pressure ≥140 mmHg or 
diastolic blood pressure ≥90 mmHg on 
two separate measurements
≥3 yrs 2,805 415 (14.8)
≥65 yrs   129 83 (64.3)
Lead poisoning Blood lead level ≥10 µg/dL 1–5 yrs 372 5 (1.3)
Malnutrition, acute Weight-for-height z-score <-2 <5 yrs 322 23 (7.1)
Malnutrition, chronic Height-for-age z-score <-2 <5 yrs 329 14 (4.3)
Obesity BMI ≥30 kg/m2 All 4,734 793 (16.8)
 ≤18 yrs  1,687 42 (2.5)
>18 yrs  3,047 751 (24.6)
Infectious
Hepatitis B HBsAg positive ≥12 yrs 2,957  21  (0.7)
>18 yrs 2,475 19 (0.8)
HIV ELISA followed by Western blot Asylees only§ 274 1   (0.4)
Intestinal parasites (any)¶ At least one positive sample from three 
stool ova and parasites tests
All 4,520 2,091 (46.3)
<5 yrs 400 88 (22.0)
B. hominis   All 1,450 (32.1)
E. nana All 218 (4.8)
D. fragilis All 169 (3.7)
G. intestinalis All 140 (3.1)
E. histolytica All 55 (1.2)
Latent tuberculosis Positive tuberculin skin test on children 
aged <12 yrs; positive IGRA on persons 
aged ≥12 yrs
≥1 yrs 4,923 692 (14.1)
≥65 yrs 153    80 (52.3)




>18 yrs 304  8 (2.6)
Abbreviations: BMI: body mass index; ELISA: enzyme-linked immunosorbent assay; FTA-ABS: fluorescent treponemal antibody absorption; 
HbsAg: hepatitis B virus surface antigen; HDL-C: high density lipoprotein cholesterol; Hgb: hemoglobin; HIV: human immunodeficiency 
virus; IGRA: interferon gamma release assay; LDL-C: low density lipoprotein cholesterol; RPR: rapid plasma reagin; TG: triglycerides; TP-PA: 
Treponema pallidum particle agglutination.
* Describes which subgroups of resettling refugees and asylees are screened for each condition.
† Specific age groups with the highest prevalence rates also are displayed.
§ Refugees were screened for HIV during the overseas medical exam until January 2010, when HIV infection was removed from the U.S. list 
of inadmissible conditions. Among 28,366 U.S.-bound Iraqi refugees tested overseas during October 2007–September 2009, three (0.01%) 
were HIV-positive.
¶ The only clearly pathogenic species found were Giardia intestinalis (seen in 3.1%) and Entamoeba histolytica (seen in 1.2%). Other identified 
species, generally considered nonpathogenic or of indeterminate significance, were intestinal protozoans or stramenopiles: Blastocystis 
hominis, Chilomastix mesnilii, Dientamoeba fragilis, Endolimax nana, Entamoeba coli, Entamoeba hartmanii, and Iodomoeba butchlii.
MMWR  Morbidity and Mortality Weekly Report
1618 MMWR  /  December 17, 2010  /  Vol. 59  /  No. 49
CDC and state public health departments should 
continue to collaborate to improve collection, review, and 
sharing of health data for arriving refugee populations. 
Timely data collection is a corollary of timely medical 
assessment. Improved planning for and communica-
tion regarding sudden increases in refugee arrival could 
help reduce the time to assessment and allow for earlier 
detection and referral of important medical conditions. A 
comprehensive and evidence-based understanding of the 
unique health profile of each incoming refugee popula-
tion ultimately would allow development of beneficial, 
population-specific, and cost-effective screening and 
therapeutic guidelines for refugees.
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What is already known on this topic?
Iraqi refugees are now the largest refugee group 
resettling to the United States; although they receive 
a standard medical exam overseas before resettle-
ment and a recommended, more comprehensive 
health assessment after arrival, information about the 
health status of Iraqi refugees from these assessments 
had not been summarized previously. 
What is added by this report?
Some infectious conditions that have been the tra-
ditional focus of refugee health assessment, such as 
latent tuberculosis, are prevalent in Iraqi refugees, but 
noninfectious, chronic conditions, such as hyperten-
sion, obesity, and dyslipidemia, also are prevalent and 
important concerns in this population.
What are the implications for public health practice?
Refugee populations resettling to the United States 
might have diverse health profiles; population-
specific health information will assist local, state, and 
federal public health agencies develop more focused 
screening, prevention, treatment, and referral efforts 
aimed at reducing morbidity and mortality.
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Emergence of Shigella flexneri 2a Resistant 
to Ceftriaxone and Ciprofloxacin — South 
Carolina, October 2010
On October 20, 2010, the South Carolina 
Department of Health and Environmental Control 
and CDC began investigating a cluster of three diar-
rheal illnesses caused by multidrug-resistant Shigella 
flexneri 2a. The index case occurred in a girl aged 
2 years who experienced the onset of diarrhea on 
September 25 and was hospitalized the next day 
because of a seizure and fever. On September 30, her 
brother, aged 6 years, was hospitalized with vomiting, 
bloody diarrhea, and hyponatremia. Three days later, 
her father was hospitalized with vomiting, bloody 
diarrhea, and hyponatremia. 
S. flexneri 2a was isolated from all three patients 
and tested for antimicrobial susceptibility using semi-
automated broth microdilution panels. Interpretations 
of susceptible, intermediate, or resistant were based on 
the most recently approved standards published by the 
Clinical and Laboratory Standards Institute (1). The 
isolates were found susceptible to imipenem, had inter-
mediate susceptibility or were resistant to ceftazidime 
and cefepime, and were resistant to ampicillin, aztre-
onam, cefotaxime, ceftriaxone, chloramphenicol, cip-
rofloxacin, nalidixic acid, streptomycin, sulfisoxazole, 
tetracycline, and trimethoprim/sulfamethoxazole. 
Azithromycin inhibited the isolates at a minimum 
concentration of 2 or 4 µg/mL, which is similar to 
the azithromycin minimum inhibitory concentra-
tions among Shigellae in the United States during 
2005–2007 (no breakpoint for Shigella susceptibility 
to azithromycin has been established) (2). 
The two children were treated sequentially with 
ceftriaxone, piperacillin/tazobactam, azithromycin, and 
clarithromycin, for a total of 25 days of treatment per 
child. The father received piperacillin/tazobactam and 
azithromycin for 6 days. The younger child’s diarrhea 
persisted for ≥16 days; Shigella organisms were isolated 
from every stool specimen tested until 24 days after 
diarrhea onset. All three patients recovered fully.
The index patient was born in China and lived there 
until being adopted and brought to the United States 
in August 2010. A playmate of hers, also adopted from 
China and believed to be aged 2 years, had diarrhea at 
approximately the same time as the index patient, but 
no further information was available. None of the other 
eight family members of the girl nor any social contacts 
have reported diarrhea since September 2010. 
Besides being associated with severe disease, the 
S. flexneri isolates were resistant to most clinically 
useful antibiotics and demonstrated a combination 
of resistance to extended-spectrum cephalosporins 
and quinolones rarely seen among Shigella organisms 
isolated in the United States (3). Transmission of this 
difficult-to-treat pathogen can be prevented by scru-
pulous hygiene, including thorough handwashing. 
Shigellosis therapy should be guided by the results of 
antimicrobial susceptibility testing, and cases should 
be reported promptly to public health officials so that 
control measures can be implemented.
Although the source of these isolates is unknown, 
internationally adopted children can be a source of 
highly resistant enteric pathogens (4). When newly 
arrived adoptees have diarrhea, stool culture for bacte-
rial pathogens should be strongly considered (5). 
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14th Annual Conference on Vaccine 
Research
The 14th Annual Conference on Vaccine Research, 
the largest scientific forum devoted exclusively to the 
research and development of vaccines and related tech-
nologies for prevention and treatment of disease through 
immunization, will be held May 16–18, 2011, at the 
Baltimore Marriott Waterfront Hotel in Baltimore, 
Maryland. The conference brings together the diverse 
fields of human and veterinary vaccinology to encourage 
collaboration and multidisciplinary approaches among 
disease-specific and methodologic experts. 
One Health initiatives, herpesvirus vaccines, the status 
of human immunodeficiency virus vaccines, genomics, 
special populations in immunology, and alternative animal 
models in vaccine discovery are among topics scheduled 
for discussion during the conference. New this year is a 
preconference workshop in academic vaccinology, Writing 
and Submitting a Vaccine Research Paper.
Applications for travel grants to subsidize attend-
ees from countries with limited resources must be 
submitted by December 27, 2010. Deadline for 
online submission of general abstracts is January 24, 
2011. Abstracts from eligible authors may be desig-
nated for consideration for the Maurice R. Hilleman 
Early-Stage Career Investigator Award, which provides 
$10,000 for research expenses and a travel stipend and 
registration for the 2012 conference. 
The vaccine research conference is sponsored by 
the National Foundation for Infectious Diseases, in 
collaboration with CDC and 13 other national and 
international agencies and organizations. Additional 
information is available at http://www.nfid.org/
conferences/vaccine11, or by e-mail (vaccine@nfid.
org), fax (301-907-0878), telephone (301-656-0003, 
ext 19), or mail (NFID, Suite 750, 4733 Bethesda 
Avenue, Bethesda, MD 20814-5278). 
Announcement
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QuickStats 
FROM THE NATIONAL CENTER FOR HEALTH STATISTICS
Percentage of Adults Aged ≥18 Years Who Experienced Serious 
Psychological Distress During the Preceding 30 Days,* by Sex and Age 
Group — National Health Interview Survey, 2009† 
* Six psychological distress questions are included in the National Health Interview Survey. Respondents are 
asked separate questions about how often during the preceding 30 days they felt 1) so sad that nothing could 
cheer them up, 2) hopeless, 3) worthless, 4) that everything was an effort, 5) nervous, or 6) restless or fidgety. 
Respondents can choose from among five response categories: all of the time, most of the time, some of the 
time, a little of the time, or none of the time. For this analysis, response values of 0 to 4 were assigned to each 
of the five response categories (with all of the time assigned 4 and none of the time assigned 0). The response 
values were summed to yield a scale with a 0–24 range. A value of 13 or more on this scale was used to define 
experiencing serious psychological distress.
† Estimates are based on household interviews of a sample of the civilian, noninstitutionalized U.S. population 
and are derived from the National Health Interview Survey sample adult component.
§ 95% confidence interval.
In 2009, women were more likely than men to experience serious psychological distress during the preceding 30 days (3.6% 
versus 2.8%). Among women, those aged 45–64 years were more likely (4.6%) to experience serious psychological distress than 
those aged 65–74 years (2.4%) and ≥75 years (2.7%). Among men, those aged 65–74 years (1.0%) were less likely to experience 
serious psychological distress than those aged 18–44 years (3.1%) and 45–64 years (2.9%).
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TABLE I. Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week ending 









Total cases reported 
for previous years States reporting cases 
during current week (No.)2009 2008 2007 2006 2005
Anthrax — — 0 1 — 1 1 —
Botulism, total 2 96 3 118 145 144 165 135
foodborne — 6 0 10 17 32 20 19
infant 1 67 2 83 109 85 97 85 FL (1)
other (wound and unspecified) 1 23 1 25 19 27 48 31 CA (1)
Brucellosis 2 116 2 115 80 131 121 120 FL (1), CA (1)
Chancroid 1 35 1 28 25 23 33 17 CA (1)
Cholera — 7 0 10 5 7 9 8
Cyclosporiasis§ — 166 2 141 139 93 137 543
Diphtheria — — — — — — — —
Domestic arboviral diseases § ,¶:
California serogroup virus disease — 71 0 55 62 55 67 80
Eastern equine encephalitis virus disease — 10 — 4 4 4 8 21
Powassan virus disease — 5 0 6 2 7 1 1
St. Louis encephalitis virus disease — 8 0 12 13 9 10 13
Western equine encephalitis virus disease — — — — — — — —
Haemophilus influenzae,** invasive disease (age <5 yrs):
serotype b 1 15 0 35 30 22 29 9 AZ (1)
nonserotype b 5 145 4 236 244 199 175 135 VT (2), CT (1), WA (2)
unknown serotype 4 240 4 178 163 180 179 217 PA (1), OH (1), MI (1), MO (1)
Hansen disease§ 1 57 1 103 80 101 66 87 CA (1)
Hantavirus pulmonary syndrome§ — 17 1 20 18 32 40 26
Hemolytic uremic syndrome, postdiarrheal§ — 212 4 242 330 292 288 221
HIV infection, pediatric (age <13 yrs)†† — — 2 — — — — 380
Influenza-associated pediatric mortality§,§§ 1 59 2 358 90 77 43 45 NY (1)
Listeriosis 7 725 15 851 759 808 884 896 NY (1), PA (1), FL (1), OR (1), CA (3)
Measles¶¶ — 59 1 71 140 43 55 66
Meningococcal disease, invasive***:
A, C, Y, and W-135 2 220 6 301 330 325 318 297 WY (1), WA (1)
serogroup B 1 100 3 174 188 167 193 156 OK (1)
other serogroup — 8 0 23 38 35 32 27
unknown serogroup 4 382 10 482 616 550 651 765 NY (1), MO (1), CO (1), CA (1)
Mumps 8 2,477 37 1,991 454 800 6,584 314 PA (1), OH (5), TX (1), WA (1)
Novel influenza A virus infections††† — 3 0 43,774 2 4 NN NN
Plague — 2 — 8 3 7 17 8
Poliomyelitis, paralytic — — — 1 — — — 1
Polio virus Infection, nonparalytic§ — — — — — — NN NN
Psittacosis§ — 4 0 9 8 12 21 16
Q fever, total§,§§§ — 110 1 114 120 171 169 136
acute — 84 1 94 106 — — —
chronic — 26 0 20 14 — — —
Rabies, human — 1 0 4 2 1 3 2
Rubella¶¶¶ — 6 0 3 16 12 11 11
Rubella, congenital syndrome — — — 2 — — 1 1
SARS-CoV§,**** — — — — — — — —
Smallpox§ — — — — — — — —
Streptococcal toxic-shock syndrome§ 2 151 2 161 157 132 125 129 VT (1), OH (1)
Syphilis, congenital (age <1 yr)†††† — 202 8 423 431 430 349 329
Tetanus — 7 1 18 19 28 41 27
Toxic-shock syndrome (staphylococcal)§ — 71 1 74 71 92 101 90
Trichinellosis — 4 0 13 39 5 15 16
Tularemia — 104 1 93 123 137 95 154
Typhoid fever 2 386 4 397 449 434 353 324 NC (1), CA (1)
Vancomycin-intermediate Staphylococcus aureus§ — 86 1 78 63 37 6 2
Vancomycin-resistant Staphylococcus aureus§ — 2 0 1 — 2 1 3
Vibriosis (noncholera Vibrio species infections)§ 11 729 5 789 588 549 NN NN VA (4), SC (1), GA (1), FL (2), WA (2), CA (1)
Viral hemorrhagic fever§§§§ — 1 — NN NN NN NN NN
Yellow fever — — — — — — — —
See Table I footnotes on next page.
Notifiable Diseases and Mortality Tables
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Notifiable Disease Data Team and 122 Cities Mortality Data Team
 Patsy A. Hall-Baker
Deborah A. Adams  Rosaline Dhara
Willie J. Anderson  Pearl C. Sharp
Michael S. Wodajo  Lenee Blanton
* Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and subsequent 4-week periods for the 
past 5 years). The point where the hatched area begins is based on the mean and two standard deviations of these 4-week 
totals.
FIGURE I. Selected notifiable disease reports, United States, comparison of provisional 4-week 


























TABLE I. (Continued) Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week 
ending December 11, 2010 (49th week)*
—: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts.
 * Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf.
 † Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. 
Additional information is available at http://www.cdc.gov/ncphi/disss/nndss/phs/files/5yearweeklyaverage.pdf.
 § Not reportable in all states. Data from states where the condition is not reportable are excluded from this table except starting in 2007 for the domestic arboviral diseases, STD data, TB 
data, and influenza-associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
 ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and 
Enteric Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
 ** Data for H. influenzae (all ages, all serotypes) are available in Table II.
 †† Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Implementation of HIV reporting influences 
the number of cases reported. Updates of pediatric HIV data have been temporarily suspended until upgrading of the national HIV/AIDS surveillance data management system is 
completed. Data for HIV/AIDS, when available, are displayed in Table IV, which appears quarterly.
 §§ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since October 3, 2010, two influenza-associated pediatric death 
occurred during the 2010–11 influenza season. Since August 30, 2009, a total of 282 influenza-associated pediatric deaths occurring during the 2009–10 influenza season have been 
reported. 
 ¶¶ No measles cases were reported for the current week.
 *** Data for meningococcal disease (all serogroups) are available in Table II.
 ††† CDC discontinued reporting of individual confirmed and probable cases of 2009 pandemic influenza A (H1N1) virus infections on July 24, 2009. During 2009, four cases of human 
infection with novel influenza A viruses, different from the 2009 pandemic influenza A (H1N1) strain, were reported to CDC. The three cases of novel influenza A virus infection reported 
to CDC during 2010 were identified as swine influenza A (H3N2) virus and are unrelated to the 2009 pandemic influenza A (H1N1) virus. Total case counts for 2009 were provided by the 
Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD).
 §§§ In 2009, Q fever acute and chronic reporting categories were recognized as a result of revisions to the Q fever case definition. Prior to that time, case counts were not differentiated with 
respect to acute and chronic Q fever cases.
 ¶¶¶ No rubella cases were reported for the current week.
 **** Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases.
 †††† Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
 §§§§ There was one case of viral hemorrhagic fever reported during week 12. The one case report was confirmed as lassa fever. See Table II for dengue hemorrhagic fever.
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TABLE II. Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
Reporting area
Chlamydia trachomatis infection Cryptosporidiosis
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 12,825 23,880 26,353 1,137,409 1,176,476 61 120 342 7,254 7,036
New England 776 759 1,396 37,830 37,914 2 7 77 434 435
Connecticut 193 198 736 9,585 10,850 — 0 71 71 38
Maine† — 49 69 1,996 2,297 — 1 7 74 47
Massachusetts 445 401 695 19,462 18,188 2 3 8 156 172
New Hampshire 37 43 114 2,331 2,013 — 1 5 52 79
Rhode Island† 87 65 120 3,293 3,438 — 0 2 13 22
Vermont† 14 23 51 1,163 1,128 — 1 5 68 77
Mid. Atlantic 1,693 3,372 5,031 161,057 149,423 11 15 38 803 785
New Jersey 367 516 691 25,340 23,131 — 1 4 37 52
New York (Upstate) 701 693 2,530 33,057 29,761 5 3 16 207 204
New York City — 1,209 2,738 57,635 55,729 — 2 6 96 80
Pennsylvania 625 942 1,092 45,025 40,802 6 8 26 463 449
E.N. Central 1,005 3,489 3,960 165,666 188,740 9 30 122 1,924 1,656
Illinois 25 746 1,191 36,047 57,937 — 4 21 265 150
Indiana — 364 797 17,957 20,956 — 3 10 143 275
Michigan 710 916 1,419 45,614 43,829 1 5 18 306 274
Ohio 156 984 1,085 45,937 46,087 7 7 24 438 366
Wisconsin 114 421 513 20,111 19,931 1 9 57 772 591
W.N. Central 164 1,367 1,556 64,031 67,044 5 22 83 1,256 1,063
Iowa 11 202 270 9,653 8,957 — 4 24 323 200
Kansas 26 189 235 8,990 10,075 — 2 9 130 101
Minnesota — 282 345 12,514 13,627 — 0 16 98 324
Missouri — 499 616 23,774 24,594 3 4 30 361 181
Nebraska† 84 94 174 4,552 5,179 2 3 26 226 115
North Dakota 25 30 89 1,622 1,763 — 0 18 31 13
South Dakota 18 62 77 2,926 2,849 — 1 6 87 129
S. Atlantic 2,871 4,710 5,664 227,430 238,240 18 18 51 969 1,089
Delaware 86 84 220 4,180 4,457 1 0 2 8 12
District of Columbia — 94 177 4,570 6,332 — 0 1 7 7
Florida 614 1,464 1,738 70,327 69,564 12 7 19 369 438
Georgia 324 625 1,216 30,363 37,788 2 5 31 285 325
Maryland† — 453 1,031 21,448 22,121 — 1 3 33 42
North Carolina 342 759 1,563 37,591 39,139 — 0 12 77 110
South Carolina† 554 524 748 25,832 25,524 1 1 8 84 59
Virginia† 883 596 902 29,482 29,858 2 2 8 90 80
West Virginia 68 73 117 3,637 3,457 — 0 3 16 16
E.S. Central 985 1,746 2,414 82,948 88,377 4 4 19 312 218
Alabama† 359 505 757 24,827 24,876 2 2 13 154 62
Kentucky 1 269 614 13,396 12,623 2 1 6 82 63
Mississippi 463 377 780 18,404 22,542 — 0 3 22 18
Tennessee† 162 563 783 26,321 28,336 — 1 5 54 75
W.S. Central 2,120 3,022 4,578 151,099 152,565 — 7 39 413 548
Arkansas† 331 268 392 11,812 13,721 — 0 3 31 57
Louisiana 429 322 1,073 15,836 26,270 — 1 6 60 55
Oklahoma 316 257 1,374 14,029 13,415 — 1 8 80 122
Texas† 1,044 2,241 3,194 109,422 99,159 — 4 30 242 314
Mountain 1,148 1,464 1,912 71,950 75,738 1 10 29 526 546
Arizona 342 515 713 24,632 24,352 — 1 3 34 33
Colorado 236 351 560 16,332 18,836 1 2 8 130 133
Idaho† 146 69 200 3,800 3,605 — 2 7 89 96
Montana† 44 60 82 2,895 2,834 — 1 4 46 55
Nevada† 199 173 337 8,818 9,623 — 0 6 31 25
New Mexico† 126 171 453 7,650 8,762 — 2 12 116 141
Utah 34 122 176 5,933 5,854 — 1 5 64 39
Wyoming† 21 36 79 1,890 1,872 — 0 2 16 24
Pacific 2,063 3,658 5,350 175,398 178,435 11 12 28 617 696
Alaska — 113 148 5,347 4,916 — 0 1 5 7
California 1,060 2,799 4,406 133,629 136,749 3 8 18 357 424
Hawaii — 111 158 5,361 5,764 — 0 1 1 1
Oregon 342 212 468 10,983 10,580 2 3 13 172 181
Washington 661 406 500 20,078 20,426 6 1 8 82 83
Territories
American Samoa — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam — 7 31 323 331 — 0 0 — —
Puerto Rico — 92 265 4,950 7,022 N 0 0 N N
U.S. Virgin Islands — 10 29 509 474 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
Dengue Virus Infection
Reporting area
Dengue Fever† Dengue Hemorrhagic Fever§
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 6 36 462 NN — 0 2 5 NN
New England — 0 3 8 NN — 0 0 — NN
Connecticut — 0 0 — NN — 0 0 — NN
Maine¶ — 0 2 5 NN — 0 0 — NN
Massachusetts — 0 0 — NN — 0 0 — NN
New Hampshire — 0 0 — NN — 0 0 — NN
Rhode Island¶ — 0 0 — NN — 0 0 — NN
Vermont¶ — 0 1 3 NN — 0 0 — NN
Mid. Atlantic — 2 12 134 NN — 0 1 1 NN
New Jersey — 0 0 — NN — 0 0 — NN
New York (Upstate) — 0 0 — NN — 0 0 — NN
New York City — 1 12 115 NN — 0 1 1 NN
Pennsylvania — 0 2 19 NN — 0 0 — NN
E.N. Central — 0 5 41 NN — 0 1 1 NN
Illinois — 0 0 — NN — 0 0 — NN
Indiana — 0 2 11 NN — 0 0 — NN
Michigan — 0 2 9 NN — 0 0 — NN
Ohio — 0 2 16 NN — 0 0 — NN
Wisconsin — 0 2 5 NN — 0 1 1 NN
W.N. Central — 0 2 17 NN — 0 0 — NN
Iowa — 0 1 2 NN — 0 0 — NN
Kansas — 0 1 1 NN — 0 0 — NN
Minnesota — 0 2 13 NN — 0 0 — NN
Missouri — 0 0 — NN — 0 0 — NN
Nebraska¶ — 0 0 — NN — 0 0 — NN
North Dakota — 0 1 1 NN — 0 0 — NN
South Dakota — 0 0 — NN — 0 0 — NN
S. Atlantic — 2 17 213 NN — 0 1 2 NN
Delaware — 0 0 — NN — 0 0 — NN
District of Columbia — 0 0 — NN — 0 0 — NN
Florida — 2 14 174 NN — 0 1 2 NN
Georgia — 0 2 11 NN — 0 0 — NN
Maryland¶ — 0 0 — NN — 0 0 — NN
North Carolina — 0 1 4 NN — 0 0 — NN
South Carolina¶ — 0 3 10 NN — 0 0 — NN
Virginia¶ — 0 3 12 NN — 0 0 — NN
West Virginia — 0 1 2 NN — 0 0 — NN
E.S. Central — 0 2 5 NN — 0 0 — NN
Alabama¶ — 0 2 2 NN — 0 0 — NN
Kentucky — 0 1 1 NN — 0 0 — NN
Mississippi — 0 1 1 NN — 0 0 — NN
Tennessee¶ — 0 1 1 NN — 0 0 — NN
W.S. Central — 0 1 4 NN — 0 1 1 NN
Arkansas¶ — 0 0 — NN — 0 1 1 NN
Louisiana — 0 0 — NN — 0 0 — NN
Oklahoma — 0 1 4 NN — 0 0 — NN
Texas¶ — 0 0 — NN — 0 0 — NN
Mountain — 0 2 16 NN — 0 0 — NN
Arizona — 0 1 6 NN — 0 0 — NN
Colorado — 0 0 — NN — 0 0 — NN
Idaho¶ — 0 1 2 NN — 0 0 — NN
Montana¶ — 0 1 3 NN — 0 0 — NN
Nevada¶ — 0 1 4 NN — 0 0 — NN
New Mexico¶ — 0 1 1 NN — 0 0 — NN
Utah — 0 0 — NN — 0 0 — NN
Wyoming¶ — 0 0 — NN — 0 0 — NN
Pacific — 0 5 24 NN — 0 0 — NN
Alaska — 0 0 — NN — 0 0 — NN
California — 0 5 11 NN — 0 0 — NN
Hawaii — 0 0 — NN — 0 0 — NN
Oregon — 0 0 — NN — 0 0 — NN
Washington — 0 2 13 NN — 0 0 — NN
Territories
American Samoa — 0 0 — NN — 0 0 — NN
C.N.M.I. — — — — NN — — — — NN
Guam — 0 0 — NN — 0 0 — NN
Puerto Rico — 109 536 9,809 NN — 0 3 42 NN
U.S. Virgin Islands — 0 0 — NN — 0 0 — NN
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Dengue Fever includes cases that meet criteria for Dengue Fever with hemorrhage, other clinical, and unknown case classifications. 
§ DHF includes cases that meet criteria for dengue shock syndrome (DSS), a more severe form of DHF.
¶ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
Ehrlichiosis/Anaplasmosis†
Reporting area
Ehrlichia chaffeensis Anaplasma phagocytophilum Undetermined
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 4 8 181 581 911 11 11 309 771 907 — 1 35 97 164
New England — 0 2 7 54 1 1 8 84 262 — 0 2 8 2
Connecticut — 0 0 — — 1 0 5 26 17 — 0 2 6 —
Maine§ — 0 1 4 6 — 0 2 16 15 — 0 0 — —
Massachusetts — 0 0 — 9 — 0 1 — 97 — 0 0 — —
New Hampshire — 0 1 3 4 — 0 3 18 19 — 0 1 2 1
Rhode Island§ — 0 1 — 34 — 0 7 24 114 — 0 0 — 1
Vermont§ — 0 0 — 1 — 0 0 — — — 0 0 — —
Mid. Atlantic — 1 15 50 190 5 3 17 211 303 — 0 2 4 44
New Jersey — 0 1 — 100 — 0 1 1 70 — 0 0 — —
New York (Upstate) — 0 15 29 54 5 3 17 207 222 — 0 1 4 6
New York City — 0 3 20 10 — 0 1 3 9 — 0 0 — 1
Pennsylvania — 0 1 1 26 — 0 0 — 2 — 0 1 — 37
E.N. Central — 0 4 32 84 — 4 39 374 279 — 1 7 61 71
Illinois — 0 2 12 33 — 0 2 7 6 — 0 2 3 3
Indiana — 0 0 — — — 0 0 — — — 0 3 27 36
Michigan — 0 1 2 6 — 0 0 — — — 0 1 4 —
Ohio — 0 3 6 13 — 0 1 2 1 — 0 0 — 2
Wisconsin — 0 1 12 32 — 4 39 365 272 — 0 4 27 30
W.N. Central 1 1 13 124 154 — 0 261 16 39 — 0 30 10 20
Iowa — 0 0 — — — 0 0 — — — 0 0 — —
Kansas — 0 1 6 6 — 0 0 — 1 — 0 0 — —
Minnesota — 0 6 — 2 — 0 261 — 33 — 0 30 — 7
Missouri 1 1 13 116 144 — 0 3 16 4 — 0 3 10 13
Nebraska§ — 0 1 2 2 — 0 0 — 1 — 0 0 — —
North Dakota — 0 0 — — — 0 0 — — — 0 0 — —
South Dakota — 0 0 — — — 0 0 — — — 0 0 — —
S. Atlantic 3 4 19 251 260 4 1 7 61 17 — 0 2 7 2
Delaware — 0 3 17 22 — 0 1 4 2 — 0 0 — —
District of Columbia — 0 0 — — — 0 0 — — — 0 0 — —
Florida — 0 2 8 12 — 0 1 3 3 — 0 0 — —
Georgia — 0 4 22 18 — 0 1 2 1 — 0 1 1 —
Maryland§ — 0 3 24 44 — 0 2 15 4 — 0 2 3 —
North Carolina 3 2 13 103 64 4 0 4 25 3 — 0 0 — —
South Carolina§ — 0 2 4 12 — 0 1 1 — — 0 0 — —
Virginia§ — 1 13 72 87 — 0 2 11 4 — 0 1 3 2
West Virginia — 0 1 1 1 — 0 0 — — — 0 1 — —
E.S. Central — 1 10 86 136 — 0 2 18 3 — 0 1 6 24
Alabama§ — 0 3 11 9 — 0 2 7 1 — 0 0 — —
Kentucky — 0 2 16 12 — 0 0 — — — 0 0 — —
Mississippi — 0 1 3 6 — 0 1 1 — — 0 0 — —
Tennessee§ — 0 6 56 109 — 0 2 10 2 — 0 1 6 24
W.S. Central — 0 141 30 30 1 0 23 7 2 — 0 1 1 —
Arkansas§ — 0 34 11 4 — 0 6 3 — — 0 0 — —
Louisiana — 0 1 1 — — 0 0 — — — 0 0 — —
Oklahoma — 0 105 15 24 — 0 16 2 1 — 0 0 — —
Texas§ — 0 2 3 2 1 0 1 2 1 — 0 1 1 —
Mountain — 0 0 — — — 0 0 — — — 0 0 — 1
Arizona — 0 0 — — — 0 0 — — — 0 0 — 1
Colorado — 0 0 — — — 0 0 — — — 0 0 — —
Idaho§ — 0 0 — — — 0 0 — — — 0 0 — —
Montana§ — 0 0 — — — 0 0 — — — 0 0 — —
Nevada§ — 0 0 — — — 0 0 — — — 0 0 — —
New Mexico§ — 0 0 — — — 0 0 — — — 0 0 — —
Utah — 0 0 — — — 0 0 — — — 0 0 — —
Wyoming§ — 0 0 — — — 0 0 — — — 0 0 — —
Pacific — 0 1 1 3 — 0 0 — 2 — 0 1 — —
Alaska — 0 0 — — — 0 0 — — — 0 0 — —
California — 0 1 1 3 — 0 0 — 2 — 0 1 — —
Hawaii — 0 0 — — — 0 0 — — — 0 0 — —
Oregon — 0 0 — — — 0 0 — — — 0 0 — —
Washington — 0 0 — — — 0 0 — — — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Cumulative total E. ewingii cases reported for year 2010 = 10.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
Reporting area
Giardiasis Gonorrhea
Haemophilus influenzae, invasive†  
All ages, all serotypes
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 219 333 666 16,841 18,085 2,956 5,578 6,386 266,463 285,888 41 59 171 2,755 2,716
New England 16 32 54 1,499 1,676 125 102 196 5,107 4,779 6 4 21 180 188
Connecticut — 5 13 236 274 62 41 169 2,214 2,326 1 0 15 44 48
Maine§ 4 4 12 220 211 — 3 11 136 130 1 0 2 13 19
Massachusetts 11 13 24 670 719 57 46 81 2,290 1,858 1 2 8 89 94
New Hampshire — 3 8 137 193 4 3 7 151 106 — 0 2 11 12
Rhode Island§ — 1 7 60 67 — 5 14 267 313 — 0 2 11 10
Vermont§ 1 4 10 176 212 2 0 17 49 46 3 0 1 12 5
Mid. Atlantic 41 62 105 3,051 3,280 377 686 1,161 34,203 30,019 5 11 34 546 545
New Jersey — 7 18 331 413 101 112 175 5,615 4,584 — 2 7 87 119
New York (Upstate) 25 22 84 1,119 1,270 131 106 422 5,496 5,481 3 3 20 151 150
New York City 4 17 33 868 793 — 228 528 11,058 10,460 — 2 6 106 69
Pennsylvania 12 14 27 733 804 145 249 366 12,034 9,494 2 4 9 202 207
E.N. Central 21 54 83 2,685 2,777 230 947 1,231 45,453 60,142 6 10 20 466 431
Illinois — 12 26 539 585 11 187 360 8,602 19,139 — 3 9 151 161
Indiana — 5 14 207 293 — 99 222 5,073 6,604 — 1 6 76 80
Michigan 2 13 25 642 634 131 247 471 12,533 14,149 1 0 3 33 24
Ohio 15 17 29 821 771 55 319 381 14,750 15,285 5 2 6 115 95
Wisconsin 4 8 32 476 494 33 93 155 4,495 4,965 — 2 5 91 71
W.N. Central 15 24 165 1,341 1,774 34 282 348 13,312 14,168 5 3 24 159 154
Iowa 2 5 11 269 282 5 33 57 1,656 1,593 — 0 1 1 —
Kansas 1 4 10 201 158 10 37 62 1,879 2,406 1 0 2 16 13
Minnesota — 0 135 136 539 — 38 62 1,761 2,203 — 0 17 25 54
Missouri 10 8 26 418 495 — 137 178 6,430 6,190 2 2 6 81 57
Nebraska§ 2 4 9 209 164 18 21 47 1,064 1,313 1 0 3 25 24
North Dakota — 0 7 29 25 — 2 11 106 134 1 0 4 11 6
South Dakota — 1 7 79 111 1 7 19 416 329 — 0 0 — —
S. Atlantic 61 70 143 3,460 3,517 821 1,347 1,789 65,877 71,235 8 14 27 713 739
Delaware 1 0 5 31 25 17 18 48 933 908 — 0 1 5 5
District of Columbia — 1 5 39 70 — 34 66 1,705 2,476 — 0 1 4 6
Florida 49 39 87 2,022 1,834 180 388 493 18,958 19,917 2 3 9 179 214
Georgia — 8 51 485 711 124 211 392 10,107 12,892 1 3 9 165 146
Maryland§ — 5 11 246 267 — 132 237 6,276 5,985 — 1 6 63 87
North Carolina N 0 0 N N 121 242 596 12,597 13,275 — 2 9 117 97
South Carolina§ 3 2 9 130 103 186 151 232 7,632 7,981 2 2 7 75 74
Virginia§ 8 9 36 461 455 176 152 265 7,123 7,346 1 2 4 75 82
West Virginia — 0 6 46 52 17 10 26 546 455 2 0 5 30 28
E.S. Central — 6 15 266 393 285 468 697 22,599 25,343 2 3 12 162 158
Alabama§ — 4 11 209 187 102 147 217 7,233 7,162 — 0 3 25 38
Kentucky N 0 0 N N — 73 142 3,475 3,657 — 1 2 32 20
Mississippi N 0 0 N N 146 110 216 5,303 6,967 1 0 2 14 8
Tennessee§ — 1 9 57 206 37 134 194 6,588 7,557 1 2 10 91 92
W.S. Central — 8 16 358 498 645 835 1,303 41,185 44,658 3 2 20 126 122
Arkansas§ — 2 7 127 145 100 77 133 3,618 4,285 — 0 3 16 21
Louisiana — 3 9 168 197 179 93 351 4,646 8,549 — 0 4 24 22
Oklahoma — 1 7 63 156 79 77 359 4,116 4,266 3 1 15 78 73
Texas§ N 0 0 N N 287 590 964 28,805 27,558 — 0 2 8 6
Mountain 9 30 50 1,549 1,578 107 177 262 8,498 8,925 3 5 15 276 234
Arizona 2 3 8 149 194 34 63 109 2,898 3,010 1 2 10 100 77
Colorado 4 13 27 656 476 16 53 95 2,541 2,659 2 1 5 79 65
Idaho§ 1 4 9 195 201 3 2 13 124 102 — 0 2 18 4
Montana§ 2 2 7 99 128 — 2 6 95 73 — 0 1 2 1
Nevada§ — 1 11 97 103 31 29 94 1,523 1,669 — 0 2 9 18
New Mexico§ — 2 5 95 110 22 20 41 1,005 1,012 — 1 5 40 33
Utah — 4 11 222 300 1 5 15 282 328 — 0 4 22 33
Wyoming§ — 1 5 36 66 — 0 4 30 72 — 0 2 6 3
Pacific 56 53 133 2,632 2,592 332 609 815 30,229 26,619 3 2 21 127 145
Alaska — 2 6 88 108 — 24 37 1,151 940 — 0 2 20 21
California 36 33 57 1,628 1,700 248 497 691 24,755 21,855 1 0 18 23 41
Hawaii — 0 4 33 20 — 14 25 693 608 — 0 2 9 30
Oregon 4 9 20 454 387 15 20 42 964 1,042 — 1 5 67 50
Washington 16 8 75 429 377 69 53 83 2,666 2,174 2 0 4 8 3
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 1 2 3 — 0 5 40 19 — 0 0 — —
Puerto Rico — 1 8 65 148 — 6 14 274 224 — 0 1 1 4
U.S. Virgin Islands — 0 0 — — — 2 7 125 114 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Data for H. influenzae (age <5 yrs for serotype b, nonserotype b, and unknown serotype) are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*

















Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 15 30 69 1,452 1,855 26 62 204 2,911 3,061 5 14 44 772 710
New England 1 2 5 89 103 — 1 5 49 52 — 1 4 41 64
Connecticut 1 0 3 28 18 — 0 2 19 15 — 0 4 27 51
Maine† — 0 1 7 1 — 0 2 13 15 — 0 0 — 2
Massachusetts — 1 5 44 67 — 0 2 9 17 — 0 2 12 10
New Hampshire — 0 1 2 7 — 0 2 6 5 N 0 0 N N
Rhode Island† — 0 4 8 8 U 0 0 U U U 0 0 U U
Vermont† — 0 0 — 2 — 0 1 2 — — 0 1 2 1
Mid. Atlantic — 4 10 196 256 2 5 10 266 311 1 2 6 105 95
New Jersey — 0 3 14 64 — 1 5 66 91 — 0 2 15 7
New York (Upstate) — 1 4 57 44 1 1 6 52 48 1 1 4 57 45
New York City — 1 5 73 84 — 1 4 78 69 — 0 1 1 5
Pennsylvania — 1 4 52 64 1 1 5 70 103 — 0 3 32 38
E.N. Central — 4 9 203 278 1 9 17 438 411 — 2 8 116 87
Illinois — 1 3 46 122 — 2 5 88 114 — 0 1 2 5
Indiana — 0 2 17 16 — 1 5 51 70 — 0 2 23 20
Michigan — 1 5 68 72 1 3 6 121 121 — 1 5 75 33
Ohio — 1 5 46 36 — 2 6 85 83 — 0 1 8 26
Wisconsin — 0 3 26 32 — 2 8 93 23 — 0 2 8 3
W.N. Central 3 1 13 77 113 1 2 15 114 134 — 0 11 25 22
Iowa — 0 3 11 35 1 0 2 14 35 — 0 1 — 10
Kansas — 0 3 12 12 — 0 2 9 6 — 0 2 3 1
Minnesota — 0 12 15 21 — 0 13 8 25 — 0 9 12 6
Missouri — 0 2 23 21 — 1 3 70 43 — 0 2 8 —
Nebraska† — 0 4 12 20 — 0 2 12 22 — 0 1 2 3
North Dakota 3 0 1 3 1 — 0 0 — — — 0 1 — 1
South Dakota — 0 1 1 3 — 0 1 1 3 — 0 0 — 1
S. Atlantic 4 7 14 327 407 9 17 40 823 836 1 4 7 165 164
Delaware — 0 1 7 4 — 0 2 23 33 U 0 0 U U
District of Columbia — 0 1 1 1 — 0 1 3 10 — 0 1 2 1
Florida 2 3 7 134 163 6 6 11 284 278 — 1 5 54 49
Georgia 2 1 3 37 50 1 3 7 139 140 — 0 2 10 31
Maryland† — 0 3 23 45 1 1 6 71 70 — 0 3 26 22
North Carolina — 1 5 47 40 — 1 16 93 100 1 1 3 42 22
South Carolina† — 0 3 22 60 1 1 4 54 53 — 0 1 1 1
Virginia† — 1 6 48 39 — 2 14 94 90 — 0 2 13 10
West Virginia — 0 5 8 5 — 0 14 62 62 — 0 5 17 28
E.S. Central — 1 5 45 41 2 8 13 337 331 — 3 8 144 100
Alabama† — 0 2 8 11 — 1 4 61 86 — 0 1 6 8
Kentucky — 0 5 23 10 1 2 8 123 86 — 2 6 100 61
Mississippi — 0 1 2 9 — 0 3 34 31 U 0 0 U U
Tennessee† — 0 2 12 11 1 2 8 119 128 — 1 4 38 31
W.S. Central 2 3 19 136 184 5 9 109 465 547 2 1 14 71 56
Arkansas† — 0 1 2 12 — 0 4 41 61 — 0 0 — 2
Louisiana — 0 2 12 6 — 1 4 45 70 — 0 1 9 8
Oklahoma — 0 1 1 6 1 2 19 90 99 2 0 12 32 13
Texas† 2 2 18 121 160 4 5 87 289 317 — 0 3 30 33
Mountain 1 3 8 138 154 — 3 8 131 124 — 1 5 50 49
Arizona — 1 5 61 64 — 0 2 30 40 U 0 0 U U
Colorado 1 1 3 35 49 — 0 5 40 25 — 0 1 12 26
Idaho† — 0 2 7 5 — 0 1 6 11 — 0 2 9 6
Montana† — 0 1 4 6 — 0 1 1 1 — 0 1 2 1
Nevada† — 0 2 14 13 — 1 3 38 32 — 0 1 6 4
New Mexico† — 0 1 5 8 — 0 1 5 6 — 0 2 11 6
Utah — 0 1 9 7 — 0 1 8 5 — 0 2 10 6
Wyoming† — 0 3 3 2 — 0 1 3 4 — 0 0 — —
Pacific 4 5 17 241 319 6 6 20 288 315 1 1 6 55 73
Alaska — 0 1 4 2 — 0 1 3 4 U 0 0 U U
California 2 4 16 196 253 5 4 16 200 223 — 0 4 21 39
Hawaii — 0 2 4 8 — 0 1 3 6 U 0 0 U U
Oregon — 0 2 17 17 — 1 3 38 41 1 0 3 15 17
Washington 2 0 2 20 39 1 1 4 44 41 — 0 6 19 15
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 6 22 7 — 1 6 43 57 — 0 7 37 49
Puerto Rico 1 0 2 14 21 — 0 2 18 34 — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
Reporting area
Legionellosis Lyme disease Malaria
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 29 57 114 3,032 3,304 88 396 2,336 26,608 35,601 17 27 89 1,383 1,328
New England 3 3 15 234 189 17 121 495 7,993 12,177 — 2 4 67 57
Connecticut 1 1 6 50 51 — 42 211 2,659 4,108 — 0 1 1 6
Maine† — 0 4 12 8 14 11 76 688 873 — 0 1 5 2
Massachusetts 2 2 10 119 89 2 39 216 2,988 5,180 — 1 3 47 36
New Hampshire — 0 5 21 14 — 23 67 1,178 1,386 — 0 2 4 4
Rhode Island† — 0 4 23 20 — 1 40 149 231 — 0 1 7 5
Vermont† — 0 2 9 7 1 4 27 331 399 — 0 1 3 4
Mid. Atlantic 9 14 44 828 1,146 39 169 733 12,043 15,480 5 7 17 377 394
New Jersey — 2 11 93 212 — 47 216 3,144 4,913 — 0 4 1 97
New York (Upstate) 8 5 19 281 339 24 47 577 2,764 3,900 3 1 6 73 48
New York City — 2 14 143 220 — 2 14 93 1,034 1 4 14 247 196
Pennsylvania 1 6 18 311 375 15 82 383 6,042 5,633 1 1 3 56 53
E.N. Central 5 11 42 676 696 1 19 273 2,453 2,936 1 2 9 138 169
Illinois — 1 15 120 127 — 1 17 123 136 — 1 7 51 69
Indiana — 2 6 102 60 — 1 7 69 82 — 0 2 8 25
Michigan 1 2 20 166 161 — 1 13 90 100 — 0 4 29 30
Ohio 4 4 15 224 274 — 0 8 36 57 1 0 5 40 35
Wisconsin — 1 11 64 74 1 15 246 2,135 2,561 — 0 1 10 10
W.N. Central 2 2 19 109 115 5 2 1,395 120 268 1 1 11 68 72
Iowa — 0 1 — 23 — 1 10 80 106 — 0 2 13 10
Kansas — 0 2 12 7 — 0 1 6 18 — 0 2 11 8
Minnesota — 0 16 35 12 — 0 1,380 — 135 — 0 11 3 32
Missouri 2 0 4 37 58 — 0 1 1 3 1 0 3 22 12
Nebraska† — 0 2 9 12 — 0 2 9 5 — 0 2 15 8
North Dakota — 0 1 7 1 5 0 15 23 — — 0 1 1 1
South Dakota — 0 2 9 2 — 0 1 1 1 — 0 2 3 1
S. Atlantic 6 10 27 518 566 23 58 175 3,629 4,264 9 7 42 399 347
Delaware — 0 3 16 19 1 11 32 606 966 — 0 1 2 5
District of Columbia — 0 4 16 23 — 0 4 30 61 — 0 2 9 17
Florida 5 3 9 168 180 5 2 10 102 105 7 3 7 130 87
Georgia — 1 4 53 58 — 0 2 11 40 — 0 5 45 66
Maryland† — 2 6 108 147 — 24 100 1,553 1,996 — 1 22 93 77
North Carolina — 1 7 56 58 4 1 9 84 93 2 0 13 49 30
South Carolina† — 0 2 11 12 — 0 3 28 41 — 0 1 4 5
Virginia† 1 1 8 76 60 13 19 79 1,094 794 — 1 5 64 58
West Virginia — 0 3 14 9 — 0 32 121 168 — 0 2 3 2
E.S. Central 1 2 10 126 138 — 1 4 44 37 — 0 3 31 31
Alabama† 1 0 2 19 17 — 0 1 2 3 — 0 1 9 9
Kentucky — 0 4 27 52 — 0 1 5 1 — 0 3 8 9
Mississippi — 0 3 10 4 — 0 0 — — — 0 2 2 4
Tennessee† — 1 6 70 65 — 0 4 37 33 — 0 2 12 9
W.S. Central 2 3 14 142 127 1 2 44 96 221 — 1 31 77 66
Arkansas† — 0 2 15 8 — 0 0 — — — 0 1 2 5
Louisiana — 0 3 8 14 — 0 1 2 — — 0 1 5 6
Oklahoma — 0 4 13 6 — 0 2 — — — 0 1 5 1
Texas† 2 2 10 106 99 1 2 42 94 221 — 1 30 65 54
Mountain — 3 10 155 141 — 0 3 25 56 — 1 4 59 48
Arizona — 1 6 59 43 — 0 1 2 6 — 0 2 23 10
Colorado — 0 5 32 29 — 0 1 3 1 — 0 3 21 26
Idaho† — 0 1 7 7 — 0 2 8 16 — 0 1 3 3
Montana† — 0 1 4 7 — 0 1 4 3 — 0 1 2 5
Nevada† — 0 2 19 14 — 0 1 1 13 — 0 1 6 —
New Mexico† — 0 2 9 9 — 0 2 5 5 — 0 1 1 —
Utah — 0 2 20 28 — 0 1 2 9 — 0 1 3 4
Wyoming† — 0 2 5 4 — 0 0 — 3 — 0 0 — —
Pacific 1 5 19 244 186 2 4 10 205 162 1 3 19 167 144
Alaska — 0 2 2 1 — 0 1 6 7 — 0 1 3 2
California — 4 19 204 144 1 3 9 136 103 1 2 13 114 109
Hawaii — 0 1 1 1 N 0 0 N N — 0 1 1 1
Oregon — 0 3 14 16 — 1 4 49 37 — 0 3 14 11
Washington 1 0 4 23 24 1 0 3 14 15 — 0 5 35 21
Territories
American Samoa — 0 0 — — N 0 0 N N — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 1 1 — — 0 0 — — — 0 0 — —
Puerto Rico — 0 1 — 2 N 0 0 N N — 0 2 4 5
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
Reporting area
Meningococcal disease, invasive† 
All groups Pertussis Rabies, animal
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 7 15 43 710 898 509 403 1,756 19,529 14,509 28 63 143 3,132 4,872
New England — 0 3 18 34 2 8 22 467 604 — 4 15 212 336
Connecticut — 0 1 3 6 — 1 8 107 54 — 0 14 59 146
Maine§ — 0 1 4 4 2 1 5 47 80 — 1 4 59 51
Massachusetts — 0 2 6 16 — 5 13 252 342 — 0 0 — —
New Hampshire — 0 0 — 3 — 0 2 19 74 — 0 5 13 32
Rhode Island§ — 0 0 — 4 — 0 9 26 43 — 0 4 31 43
Vermont§ — 0 1 5 1 — 0 4 16 11 — 1 3 50 64
Mid. Atlantic 1 1 4 70 102 133 31 100 1,740 1,142 9 19 41 993 541
New Jersey — 0 2 17 17 — 3 9 132 231 — 0 0 — —
New York (Upstate) 1 0 3 12 23 80 11 69 654 223 9 9 19 483 419
New York City — 0 2 16 17 — 0 9 78 92 — 2 12 120 22
Pennsylvania — 0 2 25 45 53 12 63 876 596 — 8 24 390 100
E.N. Central — 2 9 121 162 72 99 174 4,830 3,011 2 2 27 226 218
Illinois — 0 3 19 44 — 16 34 828 615 — 1 11 114 82
Indiana — 0 3 26 34 — 9 26 526 366 — 0 0 — 25
Michigan — 0 3 22 20 5 27 55 1,336 828 2 1 5 67 65
Ohio — 0 2 31 42 67 29 80 1,693 1,035 — 0 12 45 46
Wisconsin — 0 3 23 22 — 8 21 447 167 — 0 0 — —
W.N. Central 1 1 5 51 82 22 35 627 2,275 2,076 — 4 16 243 372
Iowa — 0 3 10 13 — 11 27 584 224 — 0 3 26 33
Kansas — 0 2 7 13 — 3 9 160 235 — 1 4 59 73
Minnesota — 0 2 2 13 — 0 601 698 421 — 0 9 26 60
Missouri 1 0 4 25 27 20 8 44 546 985 — 1 6 66 65
Nebraska§ — 0 2 5 11 2 4 13 209 134 — 1 4 51 77
North Dakota — 0 1 2 1 — 0 30 50 29 — 0 5 15 11
South Dakota — 0 1 — 4 — 0 5 28 48 — 0 0 — 53
S. Atlantic — 2 7 126 159 42 29 78 1,546 1,547 17 21 73 1,041 2,031
Delaware — 0 1 2 2 — 0 4 14 13 — 0 0 — —
District of Columbia — 0 0 — — — 0 1 8 7 — 0 0 — —
Florida — 1 5 57 51 5 5 28 304 490 — 0 60 72 161
Georgia — 0 2 13 31 4 4 18 228 219 — 0 6 — 390
Maryland§ — 0 1 8 10 — 3 8 124 141 — 6 14 344 372
North Carolina — 0 2 15 31 — 0 32 129 196 — 0 5 — 456
South Carolina§ — 0 1 10 11 3 5 19 334 248 — 0 0 — —
Virginia§ — 0 2 19 17 22 5 18 280 202 16 10 25 548 538
West Virginia — 0 2 2 6 8 1 21 125 31 1 1 7 77 114
E.S. Central — 1 3 39 34 5 15 34 737 770 — 3 7 141 136
Alabama§ — 0 1 7 11 — 4 8 188 292 — 1 4 49 —
Kentucky — 0 2 17 6 — 5 14 263 219 — 0 4 21 45
Mississippi — 0 1 5 3 — 1 8 71 74 — 0 1 1 4
Tennessee§ — 0 2 10 14 5 4 11 215 185 — 1 4 70 87
W.S. Central 1 1 9 82 87 82 57 753 2,790 3,130 — 0 30 69 889
Arkansas§ — 0 1 6 9 7 3 29 183 334 — 0 7 28 41
Louisiana — 0 4 14 18 — 1 3 38 145 — 0 0 — —
Oklahoma 1 0 7 16 14 2 0 41 91 75 — 0 30 41 33
Texas§ — 1 7 46 46 73 48 681 2,478 2,576 — 0 7 — 815
Mountain 2 1 6 53 60 109 27 97 1,621 965 — 1 8 80 104
Arizona — 0 2 13 13 1 7 16 387 256 — 0 5 — —
Colorado 1 0 4 21 21 108 4 86 545 221 — 0 0 — —
Idaho§ — 0 1 5 7 — 3 15 183 95 — 0 2 11 8
Montana§ — 0 1 1 5 — 1 16 98 58 — 0 3 17 25
Nevada§ — 0 1 8 4 — 0 7 32 24 — 0 2 8 6
New Mexico§ — 0 1 3 3 — 2 11 129 76 — 0 2 13 26
Utah — 0 1 1 2 — 4 13 237 213 — 0 2 10 13
Wyoming§ 1 0 0 1 5 — 0 2 10 22 — 0 4 21 26
Pacific 2 3 16 150 178 42 45 210 3,523 1,264 — 2 12 127 245
Alaska — 0 1 1 6 — 0 6 38 56 — 0 2 12 12
California 1 2 13 100 110 6 31 182 2,694 660 — 2 12 102 222
Hawaii — 0 1 1 5 — 0 6 42 45 — 0 0 — —
Oregon — 1 2 31 41 2 6 16 311 246 — 0 2 13 11
Washington 1 0 7 17 16 34 5 38 438 257 — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — 2 — 0 0 — —
Puerto Rico — 0 0 — 1 — 0 1 3 1 — 1 3 40 39
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Data for meningococcal disease, invasive caused by serogroups A, C, Y, and W-135; serogroup B; other serogroup; and unknown serogroup are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
Reporting area
Salmonellosis Shiga toxin-producing E. coli (STEC)† Shigellosis
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 447 953 1,727 48,562 46,196 46 85 210 4,543 4,341 197 277 527 13,155 14,778
New England 8 32 480 2,191 2,097 1 2 53 193 289 — 4 67 301 331
Connecticut — 0 464 464 430 — 0 53 53 67 — 0 62 62 43
Maine§ 5 2 7 127 118 — 0 3 20 19 — 0 1 8 5
Massachusetts 3 23 52 1,228 1,100 — 1 9 79 105 — 4 16 207 231
New Hampshire — 3 10 157 255 — 0 2 21 35 — 0 1 12 21
Rhode Island§ — 2 17 140 134 — 0 1 2 38 — 0 3 11 26
Vermont§ — 1 5 75 60 1 0 2 18 25 — 0 1 1 5
Mid. Atlantic 41 96 219 5,468 5,238 4 9 32 531 411 5 33 53 1,492 2,675
New Jersey — 19 57 1,012 1,077 — 2 9 102 101 — 6 16 331 566
New York (Upstate) 29 25 78 1,371 1,249 4 3 13 194 143 4 3 19 216 215
New York City 1 25 56 1,284 1,214 — 1 7 77 56 — 5 14 282 437
Pennsylvania 11 31 82 1,801 1,698 — 2 13 158 111 1 13 34 663 1,457
E.N. Central 20 88 245 5,109 4,968 3 9 39 698 698 5 26 238 1,578 2,420
Illinois — 28 114 1,717 1,418 — 2 9 121 164 — 9 228 769 591
Indiana — 11 62 623 598 — 1 9 67 94 — 1 5 38 73
Michigan 4 15 48 882 928 — 2 16 149 134 1 5 9 236 215
Ohio 16 24 47 1,262 1,360 3 3 11 139 127 4 5 23 293 1,056
Wisconsin — 9 45 625 664 — 3 17 222 179 — 4 21 242 485
W.N. Central 37 46 98 2,390 2,524 10 11 39 634 709 11 43 88 1,951 1,209
Iowa 1 9 34 507 383 — 2 16 167 155 1 1 5 49 52
Kansas 1 7 19 426 384 1 1 6 73 54 3 5 14 256 196
Minnesota — 0 32 178 536 — 0 13 31 205 — 0 3 14 75
Missouri 31 13 44 818 634 7 4 27 240 136 6 36 75 1,569 844
Nebraska§ 3 4 13 242 335 2 1 6 74 84 1 1 10 56 34
North Dakota 1 0 39 51 64 — 0 10 17 8 — 0 5 — 4
South Dakota — 3 17 168 188 — 0 4 32 67 — 0 2 7 4
S. Atlantic 213 262 610 15,052 13,726 6 13 30 709 641 55 46 133 2,578 2,269
Delaware 1 3 11 172 140 — 0 2 6 13 — 0 4 40 145
District of Columbia — 1 6 75 96 — 0 1 6 2 — 0 4 25 26
Florida 117 118 227 6,031 6,344 4 4 13 235 165 42 19 53 1,106 444
Georgia 23 41 132 2,655 2,304 — 1 15 103 69 10 14 39 746 632
Maryland§ 2 17 54 980 774 — 2 9 97 90 — 2 8 124 360
North Carolina 18 30 209 2,287 1,717 — 1 10 90 106 2 3 36 231 351
South Carolina§ 35 21 98 1,606 1,141 — 0 2 22 33 1 1 5 67 122
Virginia§ 17 18 68 1,076 1,002 2 2 15 129 134 — 3 15 136 180
West Virginia — 2 16 170 208 — 0 4 21 29 — 0 66 103 9
E.S. Central 16 55 177 3,763 2,970 1 4 22 258 208 11 13 40 722 776
Alabama§ 5 19 52 1,001 888 — 1 4 51 46 7 3 14 209 149
Kentucky 4 10 31 555 436 — 1 6 68 69 — 3 28 218 217
Mississippi 1 17 67 1,181 885 — 0 12 30 6 — 1 4 52 47
Tennessee§ 6 14 53 1,026 761 1 2 7 109 87 4 5 14 243 363
W.S. Central 12 110 547 5,871 5,664 — 5 68 275 298 65 53 251 2,619 2,793
Arkansas§ 6 12 43 761 591 — 1 5 47 44 3 1 9 76 298
Louisiana 1 19 49 1,195 1,151 — 0 2 19 23 1 5 13 262 171
Oklahoma 5 12 46 643 590 — 0 27 40 32 1 6 96 251 279
Texas§ — 61 477 3,272 3,332 — 3 41 169 199 60 41 144 2,030 2,045
Mountain 7 49 105 2,621 2,897 4 11 34 609 549 4 15 32 763 1,097
Arizona 1 17 42 884 1,036 3 1 10 86 66 1 8 18 408 784
Colorado 5 10 24 552 590 — 3 21 209 164 3 2 6 97 93
Idaho§ 1 3 9 158 166 1 2 7 102 88 — 0 3 23 8
Montana§ — 2 7 84 105 — 1 5 40 35 — 0 1 6 11
Nevada§ — 4 22 279 246 — 0 5 32 34 — 1 6 47 70
New Mexico§ — 6 19 315 354 — 1 5 43 37 — 2 10 139 103
Utah — 6 17 310 307 — 1 7 82 110 — 1 4 43 24
Wyoming§ — 1 5 39 93 — 0 2 15 15 — 0 0 — 4
Pacific 93 117 299 6,097 6,112 17 10 46 636 538 41 21 64 1,151 1,208
Alaska — 1 5 78 65 — 0 1 2 1 — 0 1 1 4
California 72 84 227 4,618 4,574 7 6 35 286 254 37 17 51 962 969
Hawaii — 4 14 210 320 — 0 4 18 11 — 0 3 22 42
Oregon — 8 48 490 416 — 2 15 117 78 — 1 4 58 51
Washington 21 15 61 701 737 10 3 19 213 194 4 1 20 108 142
Territories
American Samoa — 0 1 2 — — 0 0 — — — 1 1 4 3
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 2 7 11 — 0 0 — — — 0 1 1 13
Puerto Rico 3 10 39 478 531 — 0 0 — — — 0 1 5 14
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*











Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 2 12 157 144 2 25 421 1,477 1,230
New England — 0 0 — 2 — 0 1 3 11
Connecticut — 0 0 — — — 0 0 — —
Maine§ — 0 0 — — — 0 1 2 5
Massachusetts — 0 0 — 1 — 0 0 — 6
New Hampshire — 0 0 — — — 0 1 1 —
Rhode Island§ — 0 0 — — — 0 0 — —
Vermont§ — 0 0 — 1 — 0 0 — —
Mid. Atlantic — 0 2 16 12 — 1 4 60 95
New Jersey — 0 0 — 2 — 0 1 — 60
New York (Upstate) — 0 1 2 — — 0 3 18 14
New York City — 0 1 1 1 — 0 4 28 7
Pennsylvania — 0 2 13 9 — 0 2 14 14
E.N. Central — 0 1 4 9 — 1 9 91 81
Illinois — 0 1 2 1 — 0 5 33 48
Indiana — 0 1 2 3 — 0 5 43 10
Michigan — 0 0 — 4 — 0 1 1 1
Ohio — 0 0 — — — 0 2 13 18
Wisconsin — 0 0 — 1 — 0 1 1 4
W.N. Central — 0 4 19 19 — 4 21 316 254
Iowa — 0 0 — 1 — 0 1 4 4
Kansas — 0 1 2 1 — 0 0 — —
Minnesota — 0 1 — 2 — 0 0 — 2
Missouri — 0 4 15 7 — 4 20 308 244
Nebraska§ — 0 1 2 8 — 0 1 3 4
North Dakota — 0 0 — — — 0 1 1 —
South Dakota — 0 0 — — — 0 0 — —
S. Atlantic — 1 9 83 66 2 9 60 502 373
Delaware — 0 1 1 — — 0 3 21 18
District of Columbia — 0 1 1 — — 0 1 — 1
Florida — 0 1 4 — — 0 2 11 7
Georgia — 1 6 57 52 — 0 0 — —
Maryland§ — 0 1 3 3 — 0 5 53 37
North Carolina — 0 3 12 7 2 2 48 268 242
South Carolina§ — 0 1 1 3 — 0 2 18 15
Virginia§ — 0 2 4 1 — 2 12 131 51
West Virginia — 0 0 — — — 0 0 — 2
E.S. Central — 0 3 19 9 — 5 29 382 253
Alabama§ — 0 1 5 3 — 1 8 75 62
Kentucky — 0 2 6 1 — 0 0 — —
Mississippi — 0 0 — — — 0 3 16 9
Tennessee§ — 0 2 8 5 — 4 20 291 182
W.S. Central — 0 3 6 9 — 1 408 111 139
Arkansas§ — 0 2 2 — — 0 110 64 70
Louisiana — 0 0 — — — 0 1 2 2
Oklahoma — 0 3 3 7 — 0 287 26 46
Texas§ — 0 1 1 2 — 0 11 19 21
Mountain — 0 1 2 17 — 0 2 12 24
Arizona — 0 1 — 11 — 0 1 2 12
Colorado — 0 0 — 1 — 0 1 1 —
Idaho§ — 0 0 — — — 0 1 5 1
Montana§ — 0 1 2 4 — 0 1 1 6
Nevada§ — 0 0 — — — 0 0 — 1
New Mexico§ — 0 0 — — — 0 1 1 1
Utah — 0 0 — — — 0 1 1 1
Wyoming§ — 0 0 — 1 — 0 1 1 2
Pacific — 0 2 8 1 — 0 0 — —
Alaska N 0 0 N N N 0 0 N N
California — 0 2 7 1 — 0 0 — —
Hawaii N 0 0 N N N 0 0 N N
Oregon — 0 1 1 — — 0 0 — —
Washington — 0 0 — — — 0 0 — —
Territories
American Samoa N 0 0 N N N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam N 0 0 N N N 0 0 N N
Puerto Rico N 0 0 N N N 0 0 N N
U.S. Virgin Islands — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Illnesses with similar clinical presentation that result from Spotted fever group rickettsia infections are reported as Spotted fever rickettsioses. Rocky Mountain spotted fever (RMSF) caused 
by Rickettsia rickettsii, is the most common and well-known spotted fever.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
Streptococcus pneumoniae,† invasive disease
Reporting area
All ages Age <5 Syphilis, primary and secondary
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 252 252 495 13,474 2,868 22 44 156 2,040 2,299 89 243 413 11,636 13,184
New England 13 10 99 725 100 — 1 24 91 95 2 9 22 433 309
Connecticut 6 0 91 342 50 — 0 22 28 22 2 1 10 89 54
Maine§ 1 2 6 112 19 — 0 1 10 8 — 0 3 23 3
Massachusetts 2 1 5 65 3 — 1 4 41 46 — 5 15 260 223
New Hampshire — 0 7 59 — — 0 1 3 11 — 0 2 22 14
Rhode Island§ — 0 36 69 15 — 0 3 3 4 — 1 4 37 15
Vermont§ 4 1 6 78 13 — 0 1 6 4 — 0 2 2 —
Mid. Atlantic 18 27 56 1,311 191 2 7 48 346 286 6 33 46 1,561 1,668
New Jersey — 2 8 99 — — 1 5 51 62 1 4 12 223 211
New York (Upstate) 4 3 12 154 82 2 2 19 113 127 1 2 11 124 115
New York City 6 10 31 587 16 — 2 24 127 82 — 18 31 861 1,015
Pennsylvania 8 9 22 471 93 — 1 5 55 15 4 7 16 353 327
E.N. Central 48 54 98 2,751 635 2 7 18 335 395 2 27 48 1,289 1,473
Illinois — 2 7 97 — — 2 5 89 68 — 8 26 434 710
Indiana — 8 24 507 237 — 1 6 43 79 — 3 14 159 150
Michigan 9 12 27 650 25 1 1 6 76 75 — 4 12 200 224
Ohio 36 22 49 1,149 373 1 2 6 92 132 2 10 19 454 346
Wisconsin 3 6 22 348 — — 1 4 35 41 — 1 3 42 43
W.N. Central 8 11 182 713 172 — 2 12 123 173 1 6 18 317 294
Iowa — 0 0 — — — 0 0 — — — 0 3 16 21
Kansas 1 2 7 101 52 — 0 2 14 18 — 0 3 18 31
Minnesota — 0 179 287 43 — 0 10 44 81 — 2 9 132 67
Missouri 2 2 10 120 65 — 1 4 40 44 — 3 9 140 166
Nebraska§ 3 2 7 127 2 — 0 2 15 14 1 0 1 7 5
North Dakota 2 0 11 62 7 — 0 1 2 5 — 0 0 — 4
South Dakota — 0 3 16 3 — 0 2 8 11 — 0 1 4 —
S. Atlantic 48 55 144 3,046 1,288 3 9 28 503 566 18 57 218 2,832 3,172
Delaware 1 0 3 39 18 — 0 0 — 3 — 0 1 4 27
District of Columbia — 0 4 24 24 — 0 2 7 6 — 2 21 145 162
Florida 21 24 89 1,361 728 2 3 18 184 194 7 21 44 1,039 989
Georgia 8 11 28 526 416 — 3 12 143 170 1 11 167 606 757
Maryland§ 3 8 31 460 4 — 1 6 48 80 — 6 14 284 289
North Carolina — 0 0 — — — 0 0 — — 2 7 22 334 546
South Carolina§ 15 7 25 468 — 1 1 4 51 46 3 2 7 140 116
Virginia§ — 1 4 50 — — 1 4 48 47 5 5 22 275 282
West Virginia — 2 21 118 98 — 0 4 22 20 — 0 2 5 4
E.S. Central 20 22 50 1,204 252 3 2 8 117 141 14 16 39 809 1,082
Alabama§ — 0 0 — — — 0 0 — — 3 5 11 234 407
Kentucky — 3 16 181 73 — 0 2 13 8 — 2 13 120 75
Mississippi 1 1 6 52 52 — 0 2 11 26 10 4 17 210 212
Tennessee§ 19 18 44 971 127 3 2 6 93 107 1 5 17 245 388
W.S. Central 54 30 91 1,766 114 10 5 41 274 327 18 36 63 1,810 2,650
Arkansas§ 2 3 9 153 53 1 0 3 17 39 3 3 12 166 264
Louisiana — 2 8 107 61 — 0 3 26 29 1 7 28 406 721
Oklahoma 1 1 5 45 — 1 1 5 45 55 1 1 7 78 88
Texas§ 51 24 83 1,461 — 8 3 34 186 204 13 24 34 1,160 1,577
Mountain 36 31 82 1,686 113 2 4 12 219 287 11 10 25 489 505
Arizona 14 11 51 724 — 2 2 7 93 118 1 3 8 149 221
Colorado 7 10 22 524 — — 1 4 63 47 — 3 8 129 95
Idaho§ — 0 2 16 — — 0 2 9 9 2 0 1 4 3
Montana§ — 0 2 21 — — 0 1 3 — — 0 2 3 4
Nevada§ — 2 4 76 40 — 0 1 5 7 6 1 9 117 89
New Mexico§ — 2 9 144 — — 0 4 16 36 2 1 4 50 60
Utah — 3 9 155 61 — 0 3 27 67 — 1 4 37 30
Wyoming§ 15 0 1 26 12 — 0 1 3 3 — 0 0 — 3
Pacific 7 5 14 272 3 — 0 7 32 29 17 43 61 2,096 2,031
Alaska — 2 9 102 — — 0 5 19 19 — 0 1 1 —
California 7 3 12 170 — — 0 2 13 — 14 35 54 1,796 1,813
Hawaii — 0 0 — 3 — 0 0 — 10 — 0 4 32 33
Oregon — 0 0 — — — 0 0 — — 1 1 7 66 54
Washington — 0 0 — — — 0 0 — — 2 4 11 201 131
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — — 4 15 202 210
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Includes drug resistant and susceptible cases of invasive Streptococcus pneumoniae disease among children <5 years and among all ages. Case definition: Isolation of S. pneumoniae from 
a normally sterile body site (e.g., blood or cerebrospinal fluid).
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending December 11, 2010, and December 12, 2009 (49th week)*
West Nile virus disease†
Reporting area
Varicella (chickenpox)§ Neuroinvasive Nonneuroinvasive¶
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 181 293 550 13,500 19,594 — 0 70 598 385 — 1 53 381 334
New England 3 14 36 708 1,042 — 0 3 13 — — 0 1 2 —
Connecticut 1 5 20 289 475 — 0 2 6 — — 0 1 1 —
Maine§ — 4 15 213 230 — 0 0 — — — 0 0 — —
Massachusetts — 0 1 2 4 — 0 2 6 — — 0 1 1 —
New Hampshire — 2 8 114 194 — 0 1 1 — — 0 0 — —
Rhode Island§ — 0 12 32 41 — 0 0 — — — 0 0 — —
Vermont§ 2 0 10 58 98 — 0 0 — — — 0 0 — —
Mid. Atlantic 29 33 62 1,556 1,971 — 0 19 125 9 — 0 13 62 1
New Jersey — 8 30 505 449 — 0 3 15 3 — 0 6 15 —
New York (Upstate) N 0 0 N N — 0 9 57 3 — 0 7 30 1
New York City — 0 0 — — — 0 7 32 3 — 0 4 8 —
Pennsylvania 29 22 40 1,051 1,522 — 0 3 21 — — 0 3 9 —
E.N. Central 62 98 176 4,531 6,197 — 0 14 75 9 — 0 7 29 4
Illinois 5 22 45 1,124 1,534 — 0 10 41 5 — 0 4 15 —
Indiana§ 6 6 35 398 431 — 0 2 5 2 — 0 2 7 2
Michigan 9 31 62 1,360 1,830 — 0 6 25 1 — 0 1 4 —
Ohio 34 29 56 1,298 1,845 — 0 1 4 — — 0 1 1 2
Wisconsin 8 6 22 351 557 — 0 0 — 1 — 0 1 2 —
W.N. Central 2 15 32 767 1,242 — 0 7 28 26 — 0 11 72 75
Iowa N 0 0 N N — 0 1 2 — — 0 2 4 5
Kansas§ — 4 22 228 538 — 0 1 3 4 — 0 3 14 9
Minnesota — 0 0 — — — 0 1 4 1 — 0 3 4 3
Missouri 2 7 23 447 568 — 0 1 3 4 — 0 0 — 1
Nebraska§ N 0 0 N N — 0 3 10 11 — 0 7 27 41
North Dakota — 0 9 37 83 — 0 2 2 — — 0 2 7 1
South Dakota — 1 7 55 53 — 0 2 4 6 — 0 3 16 15
S. Atlantic 16 35 100 2,004 2,482 — 0 4 33 16 — 0 4 22 2
Delaware§ — 0 3 25 12 — 0 0 — — — 0 0 — —
District of Columbia — 0 4 18 30 — 0 1 1 2 — 0 1 1 —
Florida§ 10 16 57 956 1,092 — 0 2 8 2 — 0 1 3 1
Georgia N 0 0 N N — 0 1 4 4 — 0 3 9 —
Maryland§ N 0 0 N N — 0 3 16 — — 0 2 7 1
North Carolina N 0 0 N N — 0 0 — — — 0 0 — —
South Carolina§ — 0 35 75 129 — 0 1 1 3 — 0 0 — —
Virginia§ 3 11 29 500 734 — 0 1 3 5 — 0 1 2 —
West Virginia 3 8 26 430 485 — 0 0 — — — 0 0 — —
E.S. Central — 6 22 280 531 — 0 1 8 37 — 0 3 11 27
Alabama§ — 5 22 273 526 — 0 1 1 — — 0 1 2 —
Kentucky N 0 0 N N — 0 1 2 3 — 0 1 1 —
Mississippi — 0 2 7 5 — 0 1 3 30 — 0 2 6 22
Tennessee§ N 0 0 N N — 0 1 2 4 — 0 2 2 5
W.S. Central 68 45 285 2,642 4,725 — 0 15 97 117 — 0 3 19 35
Arkansas§ — 2 32 129 477 — 0 3 6 6 — 0 1 1 —
Louisiana — 2 5 81 131 — 0 3 14 10 — 0 1 6 11
Oklahoma N 0 0 N N — 0 0 — 8 — 0 0 — 2
Texas§ 68 39 272 2,432 4,117 — 0 15 77 93 — 0 2 12 22
Mountain 1 20 36 945 1,310 — 0 18 152 77 — 0 15 125 123
Arizona — 0 0 — — — 0 13 104 12 — 0 9 58 8
Colorado§ — 8 18 379 506 — 0 5 26 36 — 0 11 55 67
Idaho§ N 0 0 N N — 0 0 — 9 — 0 1 1 29
Montana§ — 3 17 185 162 — 0 0 — 2 — 0 0 — 3
Nevada§ N 0 0 N N — 0 0 — 7 — 0 1 2 5
New Mexico§ 1 2 8 94 114 — 0 5 19 6 — 0 2 4 2
Utah — 5 17 273 528 — 0 1 1 1 — 0 1 1 1
Wyoming§ — 0 3 14 — — 0 1 2 4 — 0 1 4 8
Pacific — 1 6 67 94 — 0 7 67 94 — 0 6 39 67
Alaska — 0 5 37 55 — 0 0 — — — 0 0 — —
California — 0 0 — — — 0 7 66 67 — 0 6 38 45
Hawaii — 0 6 30 39 — 0 0 — — — 0 0 — —
Oregon N 0 0 N N — 0 0 — 1 — 0 0 — 10
Washington N 0 0 N N — 0 1 1 26 — 0 1 1 12
Territories
American Samoa N 0 0 N N — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 2 15 32 — 0 0 — — — 0 0 — —
Puerto Rico 2 9 30 527 490 — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Case counts for reporting year 2010 are provisional and subject to change. For further information on interpretation of these data, see http://www.cdc.gov/ncphi/disss/nndss/phs/files/
ProvisionalNationa%20NotifiableDiseasesSurveillanceData20100927.pdf. Data for HIV/AIDS, AIDS and TB, when available, are displayed in Table IV, which appears quarterly.
† Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNET Surveillance). Data for California 
serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
¶ Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases and influenza-
associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
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TABLE III. Deaths in 122 U.S. cities,* week ending December 11, 2010 (49th week)
Reporting area
All causes, by age (years)
P&I† 
Total Reporting area




Ages ≥65 45–64 25–44 1–24 <1
All  
Ages ≥65 45–64 25–44 1–24 <1
New England 553 383 127 29 8 6 49 S. Atlantic 1,329 820 361 88 28 31 78
Boston, MA 139 79 38 13 6 3 12 Atlanta, GA 168 94 51 17 4 2 13
Bridgeport, CT 23 15 7 1 — — — Baltimore, MD 218 115 74 16 8 4 21
Cambridge, MA 18 13 5 — — — 1 Charlotte, NC 135 102 27 3 — 3 12
Fall River, MA 27 20 4 3 — — 2 Jacksonville, FL 183 113 51 12 2 5 7
Hartford, CT 57 37 15 5 — — 5 Miami, FL 141 97 34 7 3 — 6
Lowell, MA 18 16 1 — — 1 1 Norfolk, VA 61 37 13 2 1 8 2
Lynn, MA 9 7 1 1 — — — Richmond, VA 59 29 22 5 3 — 2
New Bedford, MA 20 15 4 1 — — — Savannah, GA 65 42 16 6 1 — 4
New Haven, CT 29 22 5 1 — 1 — St. Petersburg, FL 47 27 16 2 1 1 1
Providence, RI 69 53 15 — — 1 4 Tampa, FL 133 91 23 10 3 6 7
Somerville, MA 4 3 1 — — — — Washington, D.C. 103 62 30 7 2 2 3
Springfield, MA 40 28 12 — — — 3 Wilmington, DE 16 11 4 1 — — —
Waterbury, CT 37 28 7 2 — — 4 E.S. Central 1,038 692 248 53 22 22 71
Worcester, MA 63 47 12 2 2 — 17 Birmingham, AL 212 140 55 10 3 4 21
Mid. Atlantic 1,999 1,390 428 102 46 30 103 Chattanooga, TN 98 75 17 3 2 1 5
Albany, NY 48 38 6 1 1 2 3 Knoxville, TN 123 79 34 5 5 — 4
Allentown, PA 21 18 2 — 1 — 3 Lexington, KY 70 41 19 4 2 4 3
Buffalo, NY 72 51 12 6 3 — 10 Memphis, TN 192 124 43 14 5 6 11
Camden, NJ 31 18 11 2 — — 3 Mobile, AL 39 28 9 1 — — 5
Elizabeth, NJ 16 10 6 — — — — Montgomery, AL 128 86 30 10 2 — 12
Erie, PA 46 38 3 4 1 — 4 Nashville, TN 176 119 41 6 3 7 10
Jersey City, NJ 20 13 5 1 1 — — W.S. Central 1,777 1,165 436 95 45 36 122
New York City, NY 1,068 762 230 46 17 11 43 Austin, TX 69 46 15 3 2 3 4
Newark, NJ 38 19 7 7 4 1 — Baton Rouge, LA 72 50 14 4 4 — —
Paterson, NJ 13 7 4 — 1 1 1 Corpus Christi, TX 85 61 22 2 — — 6
Philadelphia, PA 296 177 79 20 8 11 8 Dallas, TX 221 135 64 11 4 7 13
Pittsburgh, PA§ 25 18 6 1 — — 4 El Paso, TX 114 81 19 7 4 3 3
Reading, PA 37 25 7 2 — 3 — Fort Worth, TX U U U U U U U
Rochester, NY 68 50 11 5 1 1 7 Houston, TX 555 350 145 31 19 10 53
Schenectady, NY 17 12 2 3 — — 2 Little Rock, AR 82 54 24 2 — 2 —
Scranton, PA 27 20 5 2 — — 2 New Orleans, LA U U U U U U U
Syracuse, NY 108 77 21 2 8 — 9 San Antonio, TX 296 188 68 22 9 9 24
Trenton, NJ 16 12 4 — — — 1 Shreveport, LA 104 70 25 4 3 2 10
Utica, NY 12 10 2 — — — 1 Tulsa, OK 179 130 40 9 — — 9
Yonkers, NY 20 15 5 — — — 2 Mountain 1,099 767 230 71 17 14 65
E.N. Central 2,056 1,387 504 100 42 23 144 Albuquerque, NM 116 85 23 5 3 — 10
Akron, OH 46 37 7 1 1 — 2 Boise, ID 76 61 12 3 — — —
Canton, OH 38 29 8 1 — — 6 Colorado Springs, CO 84 63 12 7 — 2 2
Chicago, IL 244 154 59 19 12 — 16 Denver, CO 83 55 18 8 1 1 4
Cincinnati, OH 100 54 33 8 2 3 6 Las Vegas, NV 323 205 79 24 10 5 20
Cleveland, OH 247 171 62 7 3 4 17 Ogden, UT 38 28 6 3 1 — 5
Columbus, OH 192 129 50 9 2 2 17 Phoenix, AZ U U U U U U U
Dayton, OH 154 112 32 7 3 — 10 Pueblo, CO 45 25 17 3 — — —
Detroit, MI 107 52 44 7 2 2 5 Salt Lake City, UT 142 101 30 7 1 3 7
Evansville, IN 58 47 9 — — 2 4 Tucson, AZ 192 144 33 11 1 3 17
Fort Wayne, IN 70 47 16 2 3 2 2 Pacific 1,820 1,297 379 83 28 31 169
Gary, IN 17 10 6 1 — — — Berkeley, CA 13 9 2 1 — 1 —
Grand Rapids, MI 72 53 13 4 2 — 4 Fresno, CA 131 91 34 4 1 1 9
Indianapolis, IN 260 169 65 11 7 8 18 Glendale, CA 38 33 5 — — — 7
Lansing, MI 51 34 16 1 — — 3 Honolulu, HI 54 41 10 2 — 1 4
Milwaukee, WI 90 63 19 6 2 — 10 Long Beach, CA 72 51 15 4 2 — 7
Peoria, IL 71 51 15 5 — — 6 Los Angeles, CA 285 190 68 15 8 4 37
Rockford, IL 62 45 13 3 1 — 4 Pasadena, CA 26 19 5 2 — — 7
South Bend, IN 27 21 4 2 — — 2 Portland, OR 147 103 38 1 2 2 15
Toledo, OH 92 61 26 4 1 — 7 Sacramento, CA 135 100 28 6 1 — 9
Youngstown, OH 58 48 7 2 1 — 5 San Diego, CA 180 123 32 10 5 10 26
W.N. Central 711 483 166 34 18 10 50 San Francisco, CA 145 109 27 5 1 2 12
Des Moines, IA 104 85 17 1 — 1 9 San Jose, CA 214 154 35 14 3 8 15
Duluth, MN 45 33 7 3 1 1 4 Santa Cruz, CA 43 32 9 2 — — 2
Kansas City, KS 42 23 13 3 2 1 4 Seattle, WA 127 85 31 7 3 1 9
Kansas City, MO 111 71 29 9 1 1 8 Spokane, WA 82 64 14 3 1 — 5
Lincoln, NE 54 39 12 1 1 1 1 Tacoma, WA 128 93 26 7 1 1 5
Minneapolis, MN 95 53 28 4 8 2 6 Total¶ 12,382 8,384 2,879 655 254 203 851
Omaha, NE 101 70 21 5 3 2 6
St. Louis, MO 5 1 3 — 1 — —
St. Paul, MN 64 48 13 3 — — 6
Wichita, KS 90 60 23 5 1 1 6
U: Unavailable.   —: No reported cases.   
* Mortality data in this table are voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and 
by the week that the death certificate was filed. Fetal deaths are not included.
† Pneumonia and influenza.
§ Because of changes in reporting methods in this Pennsylvania city, these numbers are partial counts for the current week. Complete counts will be available in 4 to 6 weeks.
¶ Total includes unknown ages.
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